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Abstract 
This thesis aims to examine the critical molecular properties that lead to good cryoprotective 
performance and use this knowledge to test novel non-toxic compounds which can be 
optimized to use as cryoprotectants (CPAs). The key properties needed to make a good CPA 
are: low toxicity; the ability to pass through membranes to get inside cells; the ability to form 
glasses at relatively high sub-zero temperatures; and the ability to inhibit ice recrystallisation 
during thawing (the growth of larger ice crystals from smaller ones). This thesis presents a 
systematic investigation of these important properties, for both traditional CPAs and novel 
compounds with cryoprotective potential. Cryopreservation trials with some of these 
compounds are carried out to assess their cryoprotective potential. 
      
      
    
     
            
       
        
        
   
Second, this thesis investigates the potential of carbohydrate-based surfactants such as n-
octyl(thio)glycosides to be a novel and accessible class of penetrating CPAs. A series of eight 
n-octyl (thio)glycosides (1a/b–4a/b) with D-glucose or D-galactose-configured head groups 
and varying anomeric configurations were evaluated for glass transition behavior and 
membrane permeability. Of these, n-octyl b-D-glucopyranoside (2b) exhibited high glass 
transition temperature (Tg), both as a neat sample and 20wt-% aqueous solution. Membrane 
permeability studies of this compound revealed cellular uptake at concentrations relevant to 
the inhibition of intracellular ice formation, thus presenting a promising lead candidate for 
further biophysical and cryopreservation studies. 
Third, this thesis presents similar studies on four trehalose derivatives in order to understand 
their cryoprotective potential. Permeability trials on these molecules showed that trehalose-di 
acetate has no cell permeability, whereas both trehalose di pivotate and trehalose tetra acetate 
have moderate permeability. The most promising candidate with high glass transition 
temperature and relatively good permeability was trehalose di pivotate, so this compound was 
used for further cryopreservation studies on THP-1 cells. 
Finally, this thesis presents the development of a novel microfluidic cell trapping device for 
cell permeability studies, which has considerable advantages over traditional techniques. Two 
microfluidic cell trapping structures were produced, combining direct laser writing (DLW) and 
soft lithography techniques. These structures were used for the hydrodynamic capturing of 
single human monocyte (THP-1) cells and tested by studying the cell volume kinetics upon the 
First, this thesis presents a Langmuir monolayer study of the effects of four common 
cryoprotective agents (dimethyl sulfoxide, ethylene glycol, glycerol and dimethyl formamide) 
on phospholipid monolayers. Four different phospholipids (DOPC, DPPC, POPC, POPE) are
studied to determine if the headgroup and level of chain saturation influence the interactions. 
It is shown that the phospholipid species can have a significant effect. DMSO showed
interesting lipid specific effects – causing expansion of DPPC monolayers but compression for 
POPC monolayers, while having little effect for DOPC and POPE. The results highlight the
importance of studying more than one model lipid system as well as the need to study 
concentrations relevant to cryopreservation.
 2 
addition of DMSO. Compared to existing technologies, the method allowed: (i) rapid capture 
of single cells without surface functionalization; (ii) the rapid exchange of solvent to generate 
osmotic gradients across the cell membrane; and (iii) real-time imaging of cells during the 
shrinkage and swelling phases due to the imaging stability provided by the traps. 
To date, the search for new CPAs has been reliant on educated guesswork and trial and error. 
This thesis systematically investigates the critical molecular properties relevant for 
cryopreservation and provides a systematic method for assessing novel molecules as alternative 
cryoprotectants. 
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Chapter 1 
Introduction and Literature Review 
 
1.1 Introduction 
Cryopreservation1 is the primary application of cryobiology and is a viable option for the 
preservation of a range of biological materials such as cells and simple tissues. Cryobiology 
fundamentally refers to understanding ultra-low temperature effects on biological systems and 
utilizing this knowledge to develop better cryopreservation protocols. Cryopreservation 
involves several steps during which cellular membranes are exposed to extreme conditions and 
severe stresses which may lead to cell death2-4. Adding chemicals called cryoprotective agents 
(CPAs) helps to minimize many of the stresses associated with freezing. CPAs help to preserve 
cell membranes, inhibit ice formation inside and outside the cells and promote vitrification 
(formation of glass)5. 
      
   
     
      
       
       
      
          
     
        
          
          
           
      
  
 
     
         
        
        
        
      
      
  
 
Advances in modern cryopreservation procedures could be divided into two themes: 
 
i)  Optimization of cryopreservation protocols for particular cell types; and 
Since glycerol and dimethyl sulphoxide (DMSO) were introduced as penetrating 
cryoprotectants6, cryopreservation methodologies have been developed for many different
types of cells. For example, we can now successfully cryopreserve red and white blood cells, 
sperm, embryos, some cancer cells and stem cells7. However, current methods have two 
significant disadvantages: i) the CPAs used are highly toxic, and generally must be rapidly 
removed upon thawing, which is expensive and time consuming and so not ideal for many
critical applications such as stem cell therapies, preservation of endangered species,
reproductive technologies etc; and ii) despite years of research, most cell types
(>hundreds) cannot be cryopreserved using existing CPAs. So, there is a need to develop 
novel cryopreservation protocols involving less toxic CPAs. Investigating the cell
biophysical response to different potential CPAs is a key step in the development of “cell-type 
specific” novel protocols 8. Given that most CPAs must enter the cell in order to provide
cryoprotection, cell permeability is one of the critical parameters in a molecule’s
cryobiological potential 9-11. Osmotic effects at the time of CPA addition may lead to cell 
damage, so understanding cell volume kinetics during the freezing process is important for 
the development of new protocols 7,11-16.
According to Mazur's “Two-Factor Hypothesis”, the cellular osmotic response is measured by 
the biophysical properties of the cells such as the cell membrane permeability to water (Lp) as
 12,13,17,18well as CPAs (Ps) and the osmotically inactive cell volume (Vb). These fundamental 
properties are unknown for many cells. Cell permeability studies with various CPAs will help 
to understand the fundamental cryobiological characteristics and thus may allow the 
development of improved cryopreservation protocols 19-24. The search for novel and less toxic 
CPAs is ongoing, to enable the successful cryopreservation of a wider variety of cells, and 
reduce the toxicity associated with traditional media 25-32.
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ii) Improvement of the cryoprotective solutions by developing less toxic novel CPAs 
 
This thesis focusses on the second theme, which requires investigating the single cell 
biophysical response to various cryoprotectants and understanding their fundamental 
cryobiological and biophysical properties. Exposing cells to (permeating) CPAs causes 
osmotic imbalances due to solute and water flux across the membranes, resulting in cell volume 
changes (cells initially shrink and then swell) leading to osmotically induced membrane 
stresses4,5,9,33, which need to be minimized. In addition, cryoprotectants may interact with cell 
membrane lipids causing phase transitions which may lead to structural changes in the 
membrane 2,3,34. Moreover, the optimum protocols vary from cell type to cell type due to their 
variable sensitivity to the freezing process and the cell-type specific biophysical properties. So, 
the development of a successful cryopreservation protocol for each cell type involves 
identification of a suitable CPA and optimization of the CPA concentration in order to reduce 
the cytotoxicity5,9,35.  
 
       
          
          
          
     
        
        
     
    
           
  
 
Simple sugars display effective cryoprotection that is correlated with their hydration37, and 
sugars such as sucrose and trehalose are accumulated in nature by a number of plant and animal 
species to protect them from freezing and dehydration damage38,39. In nature these sugars are 
accumulated inside cells, and so can perform their functions naturally. However, they are not 
membrane permeable so have limited use as artificial cryoprotectants. This has inspired a 
search for non-toxic, low molecular weight compounds based on carbohydrates that exhibit 
strong cryoprotection. It has been shown that among these, substituted aryl glycosides and 
amphiphilic carbohydrates, including surfactants and hydrogelators, are promising40-42. These 
compounds display low cytotoxicity and can be readily synthesized from abundant and 
renewable starting materials. The importance of the carbohydrate head group and tail group 
hydrophobicity for tuning ice recrystallization inhibition (IRI) has recently been 
demonstrated43,44. However, while IRI activity is desirable, it is not sufficient to make a good 
CPA – the primary requirements are the ability to permeate biological membranes and the 
ability to promote intracellular vitrification. Surprisingly, there has been very little work in 
understanding these aspects in potential synthetic CPAs. The importance of cell permeability 
has been highlighted in a recent review45, and if the search for new CPAs is to be successful, 
            
      
        
       
        
         
            
          
           
             
              
    
  
     
     
 
   
       
 
   
Many solutes have been studied to determine if they might act as CPAs, reviewed in7,33. The 
most widely used CPAs are DMSO and glycerol. However, these CPAs are toxic to cells and 
recovery rates can be low. The key properties needed to make a good CPA are: low toxicity; 
the ability to pass through membranes to get inside cells; the ability to form glasses at relatively 
high sub-zero temperatures; and the ability to inhibit ice recrystallization during thawing (the 
growth of larger ice crystals from smaller ones). The CPAs used to date usually have some of 
these properties, but not all. For example, DMSO36 and glycerol have high glass 
transition temperatures and high membrane permeability, but are moderately toxic, causing 
membrane disruption at high concentration, and do not inhibit ice recrystallization upon 
thawing. So, novel materials that overcome the limitations of existing CPAs are desired to 
facilitate the effective preservation of not only cells but also (potentially) simple tissues and 
organs.
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high quality characterization of both permeability and vitrification propensity are essential. In 
addition, it is also important to understand how potential cryoprotectants interact with the 
membrane lipids. Despite their importance, the interaction between penetrating cryoprotectants 
and membranes is poorly understood in contrast with non-penetrating cryoprotectants such as 
sugars whose mechanisms of action have been extensively studied34,46-50.  
The following sections (1.2-1.8) provide a detailed literature review about the fundamentals of 
cryobiology, the importance of cryoprotectants and their mechanisms of action. 
1.2 Cryobiological damage at the cellular level  
For many organisms and cells, moderately low temperatures per se are not particularly 
damaging. However, freezing is often lethal. The formation of an ice crystal is stochastic, 
which means that the probability of ice formation is proportional to the volume of water 
available - at a given sub-zero temperature, ice is more likely to form in a large volume than a 
small volume. As the volume of any individual cell is much lower than the volume of the 
extracellular aqueous environment, ice will normally form in the extracellular space first. 
Ice, however, is a poor solvent – water molecules need to align very specifically with each 
other in order to form crystalline ice, and the inclusion of any contaminant (salts or other 
solutes) would disrupt the ice structure. Therefore when an ice crystal forms, it forms as very 
pure water ice, with very low concentrations of other molecules 51. Thus, the formation of ice 
outside the cells leads to freeze-concentration of the solutes into a co-existing unfrozen 
fraction. This fraction will have a much higher concentration of salts, sugars, proteins etc than 
the isotonic solution.  
 
As a consequence of the increased external concentration, water efflux occurs through the cell 
membrane in order to restore the osmotic equilibrium. The next step is determined by the 
cooling rate: if the cooling rate is low enough that the cells have time to expel water and re-
equilibrate, the cells will be dehydrated, and will be exposed for long periods to high 
concentrations of solutes, which can be toxic. This situation is shown schematically in Fig.1.1. 
Damage under this regime is often known as solution effects injury, as this leads to many 
irreversible changes, especially damage due to freeze-induced dehydration. On the other hand, 
if the cells are cooled too fast, the aqueous solution inside the cells becomes supercooled, and 
eventually ice will nucleate inside the cells. This is called “intracellular ice formation” and 
usually causes irreparable cell damage5,12,52. Therefore, an intermediate cooling rate is usually 
ideal as it provides the best compromise between cytotoxicity and ice formation 13,53,54, as first 
proposed by Mazur – the “Two-factor hypothesis”12,17. According to this model, there should 
be an optimum cooling rate where there is maximum cell viability. 
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Fig.1.1: Schematic representation of some key aspects of cryopreservation: (A) 
cooling rate dependent cell viability during freezing: When the cells are 
cryopreserved, seeding of ice crystal happens initially in the extracellular space and 
the cells shrink depending on the cooling rate due to osmotic dehydration. With the 
addition of a suitable cryoprotectant, in many cases there is an intermediate cooling 
rate for maximum cell viability (adapted from Reference13) (B) Mazur’s Two-factor 
hypothesis for maximum cell viability -‘‘solution effects’’ at slow cooling rates and 
“Intracellular ice formation (IIF)” at high cooling rates, with maximum viability at 
some intermediate, optimum cooling rate4,17. 
 
 
The actual value of any optimal cooling rate is determined by the osmotic properties of the 
cells and can vary enormously with different cell types. This will be discussed in more detail 
later. If an optimum cooling rate is found, the cells will undergo moderate shrinking, 
concentrating the intracellular solutes. There is a minimum critical volume below which the 
cell can no longer respond osmotically which is called the osmotically inactive volume. Below 
this value, the cell is considered to be too dehydrated leading to irreversible damage. To prevent 
dehydration, measures have to be taken to stop the separation of water into pure ice and instead 
have the entire intracellular solution solidify, forming an amorphous glass (vitrification). 
Addition of CPAs helps to avoid IIF at rapid cooling rates, helps to depress the equilibrium 
freezing point and promote vitrification. 
 
Thus, cryobiological damage at the cellular level can generally be split into three effects: 
(i) low temperature; (ii) direct freezing effects; and (iii) indirect freezing effects. In many cases 
low temperature per se is not a major cause of damage and is more closely related to chilling 
damage 55,56. Thus, in practical terms there are two major causes of damage: (i) intracellular 
ice formation (IIF); and the indirect effects of ice formation – the stress due to volume 
excursions and concentration effects as a result of cell osmotic responses. Most of these stresses 
(A) (B) 
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are related to dehydration and the transport of water across the cell membrane5,24. Basic 
knowledge of the multifaceted nature of freezing damage and the discovery of prevention 
methods, has led to the long-term storage of a number of biological cells.   
   
Cryoprotective agents are the substances used to protect biological materials from freezing 
damage. CPAs serve to prevent damage induced by the freezing process, in part by reducing 
ice crystal formation and by reducing stress resulting from osmotic shock and dehydration. 
Consequently, variables such as cell size and membrane permeability are important factors in 
selecting appropriate cryoprotectants33. Based on their ability to diffuse across cell membranes, 
CPAs are usually classified into two broad categories: Penetrating (permeating) and non-
penetrating (non-permeating) agents. Permeating cryoprotectants pass through the cell 
membrane whereas the non-permeating ones do not 57. Fig.1.2 gives a schematic representation 
of the manner by which penetrating and non-penetrating cryoprotectants (CPAs) exert their 
actions upon cells. Both cause the reduction of intracellular water, potentially protecting the 
cells from lethal intracellular ice33.  
Although many individual compounds have been reported to convey a protective effect in 
various cellular systems 33,58,59, current cryopreservation techniques are mainly based on using 
additives such as glycerol and dimethyl sulfoxide (DMSO). Polyethylene glycol, propylene 
glycol, polyvinyl pyrolidone, sorbitol, dextran and trehalose are other CPAs that have been 
used occasionally, either alone or in combination. Common groups of penetrating and non-
penetrating CPAs are discussed in the following sections 33,58. 
 
    
Penetrating cryoprotectants make the cells contract first and then swell because of 
the initial movement of water out of the cell, followed by the influx of both 
cryoprotectant and water. By contrast, non-penetrating cryoprotectants cause the 
cells to contract, but because they do not penetrate, lead to dehydration 33. 
1.3 Cryoprotective agents
Fig.1.2: Differing actions of penetrating and non-penetrating CPAs:
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1.3.1 Penetrating (permeating) cryoprotectants 
Penetrating cryoprotectants are generally small, non-ionic molecules which are highly water 
soluble at low temperatures. Given time, these molecules can diffuse through cellular 
membranes, permeating the cell and reaching equilibrium in the cytoplasm without significant 
dehydrating. Penetrating cryoprotectants need to be able to both lower the freezing point and 
increase the glass transition temperature, while reducing the amount of IIF at a given 
temperature. Additionally, penetrating cryoprotectants act as a solvent and reduce the effective 
salt concentration in the remaining intracellular water fraction, thereby provide buffering 
against the salt-induced stress. Common groups of permeating CPAs include sulfoxides, 
alcohols and amides & imides 33,58. 
1.3.2 Non-penetrating (Non-permeating) cryoprotectants 
Non-penetrating cryoprotectants are generally sugars or long chain polymers and are too large 
to permeate cells. These compounds increase the osmolarity of the extracellular environment, 
which results in cellular dehydration (and therefore higher solute concentrations) which 
reduces the chance of intracellular ice crystal formation 33. It is also postulated that some non-
permeating cryoprotectants may absorb on membrane surfaces, inhibiting ice crystal formation 
in the immediate vicinity of the cell by keeping ice in the amorphous state 33,58,60. Additionally, 
non-penetrating cryoprotectants are often included in the cell thawing media to help avoid 
osmotic shock 2,7,33,61. Upon thawing, traumatic cell expansion and lysis can occur during the 
accompanying water influx. Common groups of non-permeating CPAs include sugars and 
macromolecules/polymers 7,33,58,59. 
1.3.3 Plant Vitrification Solutions (PVS) 
Since the discovery that certain cryoprotectants help the cell survival at ultra-low temperatures, 
various solution compositions combining many cryoprotectants have been developed for plant 
cells. Due to their role in preventing ice formation inside the cell by encouraging the formation 
of glass, these solutions are called “vitrification solutions” or “vitrifying” solutions 62.  
Vitrification Solutions (VSs) are aqueous cryoprotectant solutions which can be cooled slowly 
to temperatures below the glass transition temperature without appreciable ice formation, either 
intra or extracellularly. They thus allow the amorphous glass status to be conserved during 
cooling and thawing, thereby avoiding crystallization 63. They usually consist of a mixture of 
permeating and non-permeating CPAs in order to slightly dehydrate samples, while avoiding 
cytotoxicity and protecting cells from crystallization of remaining water molecules. Among the 
vitrification solutions developed for freezing plant tissues, PVS2 (Plant Vitrification Solution 
2), designed by Sakai et al. for citrus callus64, has been successfully used for the 
cryopreservation of many species65. PVS2 is the most commonly used cryoprotectant solution 
for plants, and its glass transition temperature is observed to be -115 °C. Though the majority 
of studies employ PVS2, PVS3 66 has been notably used for cooling wasabi 67, asparagus 66 and 
garlic 68,69 shoot apices. Suranthran, P., et al. evaluate the effect of five vitrification solutions 
(VSs) on the cryopreservation and viability of oil palm poly embryoids70. In several studies, 
 9 
alternative VSs are designed by increasing or decreasing the concentration of the constitutive 
cryoprotectants (mainly glycerol and sucrose) of the original PVS2 and PVS3 71,72.  
 
The cryoprotectants most commonly used in vitrification protocols are dimethyl sulfoxide 
(DMSO), ethylene glycol (EG), glycerol and sucrose. DMSO, originally used to cryoprotect 
red blood cells and spermatozoa 73, is one of the most widely employed cryoprotectants for 
animals, plants and micro-organisms. It permeates cells very rapidly, even at low temperature, 
and has a good glass-forming tendency 57,63. EG is known for its rapid permeability and ice 
blocking tendency. Glycerol is less permeable than DMSO and EG, due to its higher molecular 
weight and viscosity. Sugars are often added in cryoprotectant mixtures as they aid dehydration 
and act as an osmotic buffer. They may also preserve the integrity of membranes in the dry 
state by substituting for water 74. In vitrification protocols, the duration of exposure of explants 
to PVS2 is usually very short due to its cytotoxicity 72. 
1.4 Effect of cryoprotectants on cell membranes 
The basic structure of a cell membrane is a lipid bilayer which controls the movement of water 
and solute molecules in and out of the cell. In this way, cell membranes act as a selective 
permeability barrier between the intracellular space and the extra cellular environment. Cell 
viability is directly related to the proper functioning of this permeability barrier. Cellular 
dehydration caused by freezing leads to changes in the membrane lipid bilayer structure 
(Fig.1.3). This may affect the normal permeability barrier function of the membrane leading to 
cell death34,75-77. There is evidence that some cryoprotectants may directly interact with cell 
membrane lipids and proteins and help to stabilize the membrane structure78,79.  
 
 
 
Fig.1.3: Schematic representation of the effect of dehydration in the cell membrane 
lipid organization: 
 (A) Without solutes cell membrane transition takes place from liquid to gel phase (B) 
Presence of solutes enables the cell membrane to remain in the fluid phase80. 
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Several studies have been carried out on the effects of non-penetrating CPAs such as sugars 
especially disaccharides and their mechanisms of action are becoming clearer 34,46,47,50,75,80-83. 
During dehydration, these solutes are known to protect cellular membranes by lowering 
deleterious phase transition temperatures 48,84,85 (Fig.1.3). The studies of the effects of sugars 
on membrane phase transitions at different hydrations suggest that these damaging effects are 
primarily due to non-specific osmotic and volumetric effects 48,80. In order to explain how sugar 
molecules help to protect from lethal phase transitions, two molecular scale theories have been 
proposed called water replacement hypothesis (WRH) and the hydration forces explanation 
(HFE)80, which are not mutually exclusive, and are discussed in detail elsewhere 34,50,81-83. 
 
      
      
     
   
    
        
     
    
       
          
      
      
      
     
       
      
       
      
      
       
        
     
1.5 Cryoprotectant toxicity and damage 
Though the purpose of cryoprotectants is to prevent damage during freezing, some of these 
compounds, especially penetrating CPAs, can themselves result in cell damage. Thus, care is 
needed in the selection of an appropriate CPA, and its concentration, to achieve effective 
cryoprotection9. The various types of CPAs, their general classification, mechanism of action, 
toxicity etc. are detailed in several publications 7,33,58-60,100-106. In addition, innovative 
approaches that integrate bio-inspired and dynamic-hydrogel cryoprotectants at high 
concentrations in tissue and organ preservation have been proposed to alleviate the existing 
toxicity problems 26,30. In particular, two recent reviews of cryoprotectant toxicity by Fahy 
104 and Best 106 summarize the major issues around cryoprotectant toxicity and toxicity 
The effects of penetrating cryoprotectants have been less widely studied, with most attention 
being given to DMSO and Glycerol 61,86-92. The interaction between DMSO and cell membrane
lipids has been studied using Small angle X-ray scattering (SAXS), differential scanning 
calorimetry (DSC), nuclear magnetic resonance (NMR), small-angle neutron scattering 
(SANS), and infrared (IR) spectroscopy as well as molecular dynamics (MD) simulations and 
the findings have been summarized elsewhere93. Many studies have shown that the influence
of DMSO on membranes is concentration-dependent 94. Yu and Quinn conducted extensive
studies of the interaction between DMSO and phospholipid membranes, demonstrating that
DMSO destabilizes the lamellar liquid-crystal phase in favour of the gel phase, summarized in 
their review paper 86. It has also been shown that DMSO can penetrate across a lipid bilayer 61 
and can limit membrane compression by partitioning between intermembrane space and 
forming a physical barrier at appropriate concentrations95. Cheng and co-workers reported from
SAXS and NMR studies that DMSO causes dehydration near DPPC lipid membrane 96, and 
this DMSO-induced dehydration has also been studied using SAXS and SANS 94. Insights into 
the molecular mechanism of the interaction of DMSO with phosphocholine bilayers has been 
gained by MD simulation studies87,89,95,97 which showed that at low concentrations, DMSO
caused membrane thinning as well as increased membrane fluidity whereas at high 
concentrations it caused pore formation. Similarly, Schrader and co-workers studied the effect
of DMSO and Glycerol on DPPC membranes and found that they have contrasting effects on 
membrane surface hydration dynamics and forces98. Gironi and co-workers measured the
effects of DMSO on bilayers in the frozen state, and noted that the presence of DMSO
significantly reduced the amount of unfrozen water, but also dehydrated the lipid headgroups99.
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reduction. There are two primary mechanisms of toxicity: toxicity to the cell membrane; and 
damage due to the oxidative effect of CPAs. The toxicity of cryoprotectants is related to the 
temperature at which they are added, the exposure time and the concentration33, so 
cryopreservation protocols try to minimize damage by optimizing these conditions. 
1.5.1 Toxicity reduction by cryoprotectant combinations 
It has been found in several studies that toxicity can be reduced by combining CPAs - multiple 
CPAs interact with each other, neutralizing the toxic effects 107,108. Penetrating CPAs are used 
with non-penetrating CPAs because extra cellular ice formation (EIF) happens more rapidly 
than IIF109. Sugar molecules show low toxicity and are often used as extracellular CPAs. Very 
early examples of this are in cryopreservation of embryos of mice 110 and cows 111. Both of 
these landmark papers utilized a protocol that combined DMSO, sucrose, and poly vinyl 
pyrrolidone. Combining multiple cryoprotectants may also alleviate, or at least reduce, toxicity 
by one cryoprotectant counteracting the negative effects of another. Many successful 
cryopreservation protocols now utilize a combination of permeating and non-permeating CPAs 
in conjunction with macromolecule supplementation, and this approach is undoubtedly a large 
reason for improved efficacy.  
1.5.2  Other means of reducing CPA toxicity 
Permeating CPAs may be added at lower temperatures in order to reduce toxicity. Different 
equilibration times may be required based on the speed of permeation of the CPAs and the cell 
type. Normally, equilibration periods are longer at lower temperatures than at higher 
temperatures33. Stepwise addition of cryoprotective agents, or gradually increasing 
concentrations, has also been used to reduce toxicity112,113. Additionally, stepwise removal of 
these compounds upon warming/thawing helps to minimize osmotic stress112,113. Furthermore, 
altering the ionic composition of the carrier solution in which the cryoprotectant is dissolved 
offers another means of mitigating damage 33,114. 
1.6 Biophysical properties of cells  
        
       
     
 
1.6.1 Determination of osmotically inactive volume !" using Boyle-Van’t Hoff 
(BVH) plot #+ (osmotically inactive volume / the osmotic ballast) is the portion of the cell volume that 
does not respond to osmotic pressure. This can be determined by exposing the cell to different 
concentrations of anisotonic solutions containing an impermeable solute and allowing for 
equilibration. The cell volume before and after exposure are calculated, assuming the cells are 
spherical. Normalized cell volumes are calculated, plotted against the inverse osmolality and 
the fitted straight line is extrapolated to find the volume at infinite osmolality which is #+ (see 
Fig.1.4). 
 
     
       
       
Cell biophysical properties include the osmotically inactive volume (Vb), water
permeability (hydraulic conductivity) and the CPA/solute permeability22,115. These
properties can be determined using mathematical equations which were first described by
Jacobs116 and later modified.
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Fig.1.4: Schematic of BVH plot representing the osmotically inactive volume #+	of 
the cell –  
Here in the example, #+	is 50% of the cell volume out of which 10% is non-osmotic 
water (also called bound water) and the remaining 40% is composed of cell solids. 
10% of cell water is bound by hydrogen bonding with macromolecules, as has been 
experimentally confirmed through differential scanning calorimetry (DSC)117,118. 
This is often called “unfreezable” water, though this terminology has been 
questioned119. 
 
1.6.2 Cell membrane permeability of cryoprotectants 
CPAs must enter the cell in order to provide cryoprotection, so cell permeability is widely 
known to be one of the most important parameters that determines the cryobiological potential 
of a molecule9-11. Osmotic effects at the time of CPA addition have significant effects on the 
cell volume kinetics during the freezing process 11-15. The permeability of a cell membrane is 
generally determined by analyzing the volume response of the cells to a change in the osmotic 
environment. As the cell membrane is more permeable to water than anything else, cells 
initially expel water in an attempt to restore osmotic balance when they are treated with 
hypertonic solutions. As a result, cells begin to shrink. If the hypertonic medium does not 
contain permeating molecules (such as salts or sugars) then it reaches a new equilibrium size. 
However, if the medium contains a permeable cryoprotectant, it slowly begins to penetrate the 
cell, and the cell responds by taking up both cryoprotecant and water and swelling back 
approximately to its initial volume 9,11. This total response of the cells can be described as 
“shrink-swell behavior” as shown in Fig.1.5. A reverse process occurs at the time of CPA 
removal after thawing.  
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Fig.1.5: Shrink–swell behavior of an individual cell upon addition of a penetrating 
CPA (adapted from Reference9).  
 
Permeability parameters can be determined using the standard estimation techniques by fitting 
the mathematical model to measurements of cell volume response during a shrink–swell 
experiment. For these experiments to be accurate, large single spherical cells are required, and 
the most efficient method is to trap single cells using a microfluidic perfusion device22,23, which 
also helps to rapidly change the cell osmotic environment. Recent work by Shu and co-
workers20 aimed to find better cryopreservation protocols for human vaginal immune cells 
through shrink-swell experiments using a microfluidic perfusion device. 
1.6.3 Estimation of permeability parameters 
There are several formalisms to find the membrane permeability parameters. Mazur and 
colleagues120,121 introduced the first one-parameter model for calculating solute permeability. 
This was refined to a two-parameter model called 2P116,122 for finding water and solute 
permeability. Kedem and Katchalsky122 developed the three-parameter model (also called the 
Kedem–Katchalsky (KK) formalism) which is most commonly used today. The KK formalism 
adds a ‘,’ term to the 2P, which is the term representing the interaction between solute and 
solvent123. An Arrhenius plot is used to find the activation energies of these permeability 
parameters123. It has been shown that the knowledge of these so-called “fundamental 
cryobiological characteristics” of the cell membranes may enable the design of protocols to 
minimize freezing damage 124,125. 
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1.7 Methods and techniques used to measure cell permeability 
A number of methods have been used to measure cell permeability, including stopped-flow 
light scattering126-128, electronic particle counters129, differential scanning calorimetry130 and 
micropipette perfusion 131. However, many of these methods have their own disadvantages 
described elsewhere11.  
The simplest method for studying cell permeability is to microscopically measure the cell 
volume change of isolated large spherical cells. Cells must not overlap and should not move 
during the osmotic excursion. A simple method of cell immobilization is the surface coating 
of the experimental device (usually coverslips) with chemicals that can provide cell attachment 
as described by Xu et al.,132,133. One disadvantage of this method is that the spherical shape of 
the cells can be lost due to surface attachment in some cases.  
Innovations in microfluidic technologies offer a tremendous potential to revolutionize 
cryopreservation. In recent years, several microfluidic devices with perfusion chambers 23 or 
single cell traps 11,134,135 have been developed, some of them specifically for the measurement 
of cell permeability 10,23,45,136,137. Microfluidic devices are now considered essential technology 
in cell biology, as they enable the user to: (i) monitor the changes of cellular conditions 
following the perfusion of various media; (ii) confine cells within a chamber/trap and 
preventing imaging ambiguity due to the overlapping of cells or their movement out of the 
focal plane; (iii) study the single cell response to osmotic pressure and calculate the cell 
membrane parameters; (iv) use low cell numbers and reagent volumes; and (v) perform kinetic 
analysis of non-adherent suspension cells by maintaining their position in place over long times 
without any dislodgement during image acquisition 23,134. Technological advances in high-
resolution three dimensional (3D) printing with direct laser writing (DLW) using multi-photon 
polymerization has enabled the fabrication of microfluidic devices in a single step 138-141. 
Compared to conventional lithography techniques, DLW accelerates the fabrication procedure, 
and more importantly, enables the fabrication of arbitrary 3D structures with high resolution 
142-146.  
1.8 Future cryoprotectants 
Currently researchers are looking to develop novel cryoprotective agents (CPAs) for the 
preservation of wide variety of cells with maximum viability and avoiding the toxicity 
associated with traditional cryopreservation media used today. Some of those recent studies 
are summarized below.  
    
        
     
         
      
     
     
        
    
A new study by Zylberberg and co-workers25 investigated non-toxic, bio-inspired DMSO-free
CPAs. These novel compounds are based on mixtures of natural compounds with antioxidative
and cell preserving properties. Preliminary cryopreservation trials with these novel compounds
have been carried out and the results were promising. Cell viabilities were tested, and results
were comparable to standard cryoprotectants based on DMSO. Another study by Demirci &
Assal26 has reported the preservation of human red blood cells with bio-inspired CPAs based 
on natural cryo-inks, such as trehalose solutions and ectoine. Briard and coworkers27,28 have
examined various natural antifreeze (glyco) proteins (AF(G)Ps) found in the inhabitants of cold 
and sub-zero environments, and these also gave promising results. Their early work led to
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developing the analogues of carbon-linked glycoprotein (C-AFGP) that shows custom-tailored 
antifreeze behaviour. These C-AFGPs are also efficient ice recrystallization inhibitors and have 
been used for the effective cryopreservation of human liver cells with reduced DMSO 
concentrations. Detailed structural and functional studies on these compounds revealed that 
several classes of carbohydrate-based molecules are very effective ice recrystallization 
inhibitors as well as effective cryoprotectants at very low concentrations. Leclere, M. et al.,29 
also published the effect of C-AFGP analogues as novel cryoprotectants. 
 
     
        
      
           
          
     
 
1.9 Aims of the thesis and Research questions 
In the context articulated above, the study of the behavior of individual cells to CPAs provides 
a starting point for analysis of how they can protect the cells from freezing damage during 
cryopreservation. So, the aims of this project are: 
 
• To understand the physical mechanisms of membrane protection by traditional 
cryoprotectants. 
• To develop techniques to investigate the critical molecular properties that lead to good 
cryoprotective performance. 
• To use this knowledge to test novel non-toxic compounds which can be optimized for 
use as CPAs 
In line with the above aims, this research aims to answer the following questions.  
• How do traditional cryoprotectants interact with cell membrane lipids? 
• Can we develop methods to more efficiently characterize the important biophysical 
parameters of potential new CPAs? 
• Is there a link between permeability of different cryoprotectants and their protective 
effects?  
1.10 Overview of the thesis 
This thesis is organized in 7 Chapters. 
Chapter 2 presents the materials and methods, and outlines the relevant experimental 
techniques used: Langmuir studies, DSC and cell volume kinetics; as well as the design and 
application of cryopreservation protocols. 
 
Another study by Mark and co-workers30 introduced dynamic-hydrogel cryoprotectants for the
preservation of tissue and organs. Nakagawa et al.,31 examined the cryoprotective ability of 
betaine-type metabolite analogs. Verdanova et al.,32 recently published an evaluation of Sericin 
as a Fetal Bovine Serum (FBS) - replacing cryoprotectant. The allergic reaction of FBS is
problematic for its use in medical applications. Sericin when used as a substitute for DMSO
and FBS in the cryopreservation medium has provided satisfactory results. The search for 
alternative cryoprotectants is thus a very active research field.
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Chapter 3 presents Langmuir studies of the effects of traditional penetrating cryoprotectants on 
cell membrane lipids. 
 
Chapter 4 reports glass transition and cell permeability studies of novel carbohydrate 
derivatives (n-Octyl glycosides and thioglycosides) to assess their potential as novel 
cryoprotectants. 
 
Chapter 5 presents the results of glass transition, cell membrane permeability and 
cryopreservation studies of modified trehalose derivatives. 
 
Chapter 6 presents an improved method for measuring cell permeability using microfluidic 
technologies. 
 
Chapter 7 integrates the work in the thesis and presents conclusions and suggestions for future 
work. 
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Chapter 2 
Methodology 
 
2.1  Langmuir monolayer technique   
The Langmuir monolayer technique is a well-established technique for studying the 
interactions between soluble molecules and lipids, and is described in detail elsewhere1. Fig. 
2.1 shows the schematic of a Langmuir trough. A monolayer of lipid is placed on the liquid 
subphase which can be water or any other solution of interest. In this study, water and CPA 
solutions are used as the subphases. Two movable barriers are used to compress the monolayer. 
As the monolayer is compressed, the surface area decreases and the corresponding increase in 
surface pressure is measured through a Wilhelmy plate electro balance connected to a pressure 
sensor. Initially the molecules will be spread unevenly (in the 2D equivalent of the gaseous 
state) and as the film is compressed the molecules become more ordered, transitioning through 
other phases. 
 
Fig.2.1: (A) schematic of a Langmuir trough with two movable barriers, monolayer 
film formed at the surface of the subphase, a wilhelmy paper plate and a pressure 
sensor. (B) shows the schematic of how the phospholipids are arranged in a 
monolayer (C) shows the schematic of how the monolayer lipids are compressed 
(Image source2). 
 
The results are visualised in Pressure-Area (! − #) isotherms (Fig.2.2A). The effects of solutes 
on lipid organization can be assessed in terms of the changes in the area per lipid molecule and 
the pressures at which phase transitions take place. The fluid and gel phases of a bilayer are 
analogous to the liquid expanded and liquid condensed phases of a monolayer respectively. 
These phases can be more clearly understood by calculating the inverse compressibility 
modulus (also called the Elasticity modulus) from the slope of the isotherm which is 
represented by Cs-1 (Eq. 2.1)1,3-9. 
 
25
%&'( = 	−# +,-,./0    (Eq. 2.1) 
The value of Cs-1 allows one to assign the monolayer physical state during compression: Cs-1 
values between 12.5-100 mN.m-1 correspond to the liquid expanded (LE) phase, 100 < Cs-1 < 
250 mN.m-1 corresponds to the liquid condensed (LC) phase, and Cs-1 > 250 mN.m-1 
corresponds to the solid (S) phase 10. Fig. 2.2 (B) shows a schematic of the Cs-1 graph. 
 
Fig. 2.2: (A) Schematic of  ! − # isotherm showing the various states achieved by 
the monolayer upon compression (B) Schematic of Cs-1 graph showing the various 
states achieved by the monolayer during compression (image source11). 
 
The results of the current study provide insights into the interactions of various cryoprotectants 
with biological cell membrane lipids which are discussed in detail in chapter 3. 
2.1.1 Materials used 
Fig. 2.3 shows the molecular structure of the phospholipids (DOPC, POPC, DPPC and POPE) 
which are commonly found in biological membranes and used in the current study for forming 
the monolayers. DOPC was purchased from Sigma-Aldrich Chemistry (Madrid, Spain) and the 
other lipids were purchased from Avanti Polar Lipids (Alabaster, AL, USA). These lipids were 
used without further purification by dissolving in chloroform (PA-ACS-ISO grade, PANREAC 
(Barcelona, Spain)) to a final concentration of 1mg.ml-1 and kept in the refrigerator. Other than 
ultrapure water (Milli Q®, 18.3 MΩcm resistivity), various penetrating CPAs (DMSO, 
glycerol, ethylene glycol and dimethyl formamide) were used as subphases for forming the 
Langmuir films. All CPA subphases were prepared as 5% v/v in ultrapure water and the 
chemicals were PA-ACS-ISO grade (PANREAC). 
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Fig. 2.3: Molecular structure of various phospholipids used as monolayers for the 
CPA-membrane lipid interaction studies. 
(Image source: https://www.sigmaaldrich.com/) 
 
2.1.2 Experiments and Equipments 
Two kinds of experiments were carried out - compression isotherms and insertion experiments. 
Langmuir compression isotherms were carried out on a NIMA teflon trough (Nima 
Technology, Coventry, UK), model 1232D1D2 (area 1200 cm2), equipped with two movable 
barriers (see Fig. 2.4 A, B), and the surface pressure was measured using a pressure sensor with 
a Wilhelmy plate (10 mm × 50 mm filter paper; Whatman International, Maidstone, UK). The 
linear velocity of the barriers was 2.5 cm.min-1, which corresponds to an area change of 50 
cm2.min-1 in the trough used. The trough was placed on a vibration-isolated table (Newport, 
Irvine, CA, USA) and enclosed in an environmental chamber. In the insertion experiments the 
effect of inserting the CPA directly into the subphase was measured by the change in surface 
pressure of the lipid monolayer. The experiments were carried out using a NIMA Langmuir 
film balance equipped with a wilhelmy plate and a small teflon trough (see Fig. 2.4 C) that was 
rinsed with chloroform and ultrapure water before use. All experiments were performed at 
22±1ºC. See chapter 3 for more details about the experimental procedure. 
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Fig. 2.4: (A) Nima teflon trough used for the Langmuir monolayer experiments (B) 
Closer view of the trough showing pressure sensor and wilhelmy plate (C) Small 
teflon trough used for insertion experiments. 
 
 
2.2  Differential scanning calorimetry (DSC)  
DSC is used to analyze the phase transition behavior of materials. In a DSC thermogram, 
generally, the high temperature peak (large exothermic peak) in the cooling cycle represents 
ice crystallization (Tc).  The inflections in the thermogram represent vitrification (glass 
transitions Tg) which is usually most clearly visible on warming cycles. Following glass 
melting in the warming run the super cooled solution undergoes freezing and a devitrification 
peak can sometimes be observed in the warming run 12,13. The ice subsequently melts as it 
reaches the freezing point and the corresponding large endothermic peak represents the melting 
temperature Tm. Fig. 2.5 shows a schematic DSC thermogram. In this study, thermograms on 
warming and cooling were obtained with Mettler Toledo DSC 3+ STARe system differential 
scanning calorimeter with a few milligrams of samples (2-10mg). Method used for the study 
is shown in Fig. 2.6.  
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Fig. 2.5: Schematic DSC thermogram showing the ice crystallization (Tc), glass 
transition (Tg) and ice melting (Tm) temperatures. Inset shows the glass transition 
part of the DSC thermogram (Image source: https://pslc.ws/macrog/dsc.htm). 
 
 
Except where stated, samples were cooled and warmed between -160°C and +25°C. For all 
samples, measurements were made on several (at least 3) successive cooling/warming runs to 
confirm the consistency in thermal behavior.  Between each run the samples were held for 
approximately 1 min at 25°C.  All scanning measurements were performed at a cooling/heating 
rate of 10°C/min and the thermograms were analyzed to determine the glass transition 
temperature. More details about the thermograms and interpretations of results are discussed 
in the upcoming experimental chapters (chapters 4&5).  
 
 
Fig. 2.6: Schematic of the DSC method used for the current study 
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 2.3 Single cell volume kinetics 
Cell permeability14-16 studies were conducted microscopically in standard media. The solute 
concentrations were rapidly increased, and the cells expel water to restore osmotic balance, 
resulting in cell shrinkage. Cell volume excursions were recorded, the volume was calculated 
as a function of time and the results were plotted. A second series of experiments were 
conducted with a permeating CPA – the cell initially shrinks as water is expelled, but the CPA 
slowly permeates, and then as the water re-entered the cell and the cell is expanded allowing 
the determination of the CPA permeability17. So, addition of a CPA to a cell suspension resulted 
in the characteristic “shrink– swell” behavior (Fig. 1.5).  
2.3.1 Materials and methods used 
The two main criteria for cell permeability studies are (i) requirement of large and spherical 
single cells and (ii) Cell immobilization without overlapping or dislodgement during image 
acquisition. For the current study, human monocyte leukemia cells (THP-1) were used which 
are spherical and large with diameters in the range of 12-18µm. Cell lines were purchased from 
ATCC (American Type Culture Collection, MANASSAS, VA). Cells were revived from liquid 
nitrogen and cultured according to ATCC standard protocol. Briefly, the cell culture consisted 
of RPMI 1640 medium (ATCC, 30-2001) supplemented with 10% FBS (Fetal Bovine Serum) 
(ATCC, 30-2020) and 1% antibiotic (Penstrep). The cells were cultured in T25 flasks (Corning) 
and incubated at 37°C in a humidified atmosphere containing 5% CO2. The cells were allowed 
to grow for 2-3 weeks with medium renewal and sub culturing. The viability of cells was 
measured using a Trypan blue exclusion test 18 and found to be in the range of 96-98% before 
experiments. The cells were collected, centrifuged at 200g for 5 min, and then re-suspended in 
RPMI 1640 medium at a density of 2.5×105 cells/mL, and used for experiments within 3 hours.  
For cell immobilization, two techniques were used:  
 
(i) Coating coverslips with Poly-L-Lysin: 
The cells were immobilized on a 15 mm diameter cover slip coated with poly-L-lysine (Sigma, 
USA) and placed in a tissue culture dish. The cell solution (50-100µL) was then loaded onto 
the cover slip for up to 15 min. Once the cells were immobilized on the cover slip, the medium 
was completely replaced by the prepared CPA solutions to achieve a rapid extracellular 
osmotic change19,20. For each experiment, new cell solutions were loaded onto the cover slips 
freshly from the incubator.  
(ii) Trapping of single cells using microfluidic devices 
The microfluidic trapping structures were fabricated at the Micro Nano Research Facility 
(MNRF) of RMIT by the author and co-workers. Structures were designed with the help of Dr. 
Khashayar Khoshmanesh from the engineering group. Schematic of the two types of cell trap 
designs (cup shaped and serpentine shaped traps) used for the current study is shown in Fig. 
2.7.  
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Fig. 2.7: Schematic of the two microfluidic cell trap designs used for the current study 
– (A) cup-shaped cell traps (B) serpentine shaped cell traps 
 
The fabrication was done by the author and Mr. Hannes Hohn (who worked as an intern student 
at RMIT from University of Applied Sciences Karlsruhe, Germany), combining Direct Laser 
Writing (DLW) and soft lithography techniques. Using DLW, a master mould can be made 
which can be repeatedly used for creating Poly di methyl siloxane (PDMS) replicas with soft 
lithography21. Fabricated microfluidic trapping devices were used for cell trapping and 
permeability studies. A schematic of the experimental setup for the cell trapping and CPA 
perfusion studies is shown in Fig. 2.8. An aliquot of cell suspension (~30-50µL) was added 
gently to the inlet of the microfluidic device and allowed to flow through the channel using a 
syringe pump (PHD 2000 Infusion, Harvard Apparatus) with a flow rate of 200µL/h in order 
to allow the hydrodynamic trapping of cells. After enough cells were trapped, the CPA 
(DMSO) solution was added for cell perfusion and permeability experiments. More details 
about the fabrication techniques and permeability studies can be found in chapter 6. 
Microfluidic cell trapping devices eliminate the limitations associated with traditional single 
cell sorting methods, such as cell overlapping, loss of sphericity due to surface attachment as 
well as the possibility of cell toxicity associated with the chemicals used for surface coating. 
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 Fig. 2.8: Experimental set up for single cell trapping and permeability studies using 
microfluidic device- (A) Schematic experimental set up (B) Setup in the laboratory 
 
An inverted microscope (Olympus IX71 inverted optical microscope) equipped with a CCD 
camera at 1024×1024 resolution and a CMOS sensor (Mikrotron MC1362) was utilized for 
visualization. Automated time-lapse image acquisition was used for periods of up to 15 min 
under the control of streampix software to capture the cell volume excursion history. The 
captured video was converted into image frames by exporting the full sequence at 1 frame/sec. 
Individual cells were cropped from each frame for image analysis. Images were extracted and 
processed using ImageJ (https://imagej.nih.gov/ij/). A few images were analyzed at regular 
time intervals to understand the volume response (shrinking and swelling) of the cells. The 
areas of the selected cells were manually measured using oval/free hand selections. Radii and 
normalized volumes were calculated assuming the cell to be a sphere. The sphericity of THP-
1 cells was evaluated as 2π	34566/89:;;, where, 89:;; is the actual cell perimeter and 34566	is the 
equivalent cell radius calculated with the two-dimensional cell area based on image analysis. 
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2.4 Cryopreservation trials 
Carbohydrate based (sugar) surfactants which showed promising cryoprotective behavior were 
used for cryopreservation studies of THP-1 cells.  Cells were cryopreserved with DMSO as a 
control. The basic protocol was the standard protocol for DMSO cryopreservation.  
2.4.1 Materials and methods 
The cell suspension was diluted to ~1 x 106 cells per mL using complete media (RPMI1640 + 
10% FBS +1% antibiotic-Penstrep). The cryo-tubes were labelled, cell samples and the CPAs 
were added to each vial in microliter (µL) amounts in order to attain the final desired CPA 
concentration. In the current studies, molar concentrations of 1.3M and 0.65M were used which 
are osmotically equivalent to the 10% and 5% by volume DMSO used in standard 
cryopreservation protocols. All procedures were carried out at room temperature. Samples 
were immediately placed in a freezing box and transferred into the -20˚C freezer for 1 hour and 
then transferred to the -80˚C freezer. The next day, the samples were transferred to Liquid 
Nitrogen (LN). After 1 week, cell viabilities were measured using a Trypan blue exclusion test 
18 after revival from LN. Initial viabilities were noted, and all cell samples were cultured in 
T25 flasks and incubated at 37°C in a humidified atmosphere containing 5% CO2. The cells 
were allowed to grow for 2 weeks with medium renewal and sub-culturing. Cell viability tests 
were repeated at each sub-culturing time. 
 
After the initial trials, final cryopreservation experiments were carried out only with the most 
promising cryoprotective candidates which showed relatively good cell viability, with slight 
variations in the basic optimized DMSO protocol described above. Four different protocols 
were tried:  
 
P-1: Bypassing the first step (transferring to freezing box), otherwise keeping the 
protocol the same. 
 
P-2: Bypassing the first step (transferring to freezing box) and then transferring directly 
to -80ºC freezer and then to LN. 
 
P-3: As for P-1 except all procedures were carried out at 4ºC instead of room 
temperature. 
 
P-4: As for P-2 except all procedures were carried out at 4ºC instead of room 
temperature. 
 
More details on the cryopreservation trials and outcomes are explained in chapter 5. 
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Abstract 
 
The influence of four common cryoprotectants (dimethyl sulfoxide, glycerol, ethylene glycol 
and dimethylformamide) on monolayers of four common phospholipids (DPPC, DOPC, POPC 
and POPE) have been studied using Langmuir isotherms and monolayer insertion experiments. 
The cryoprotectant concentrations were chosen to be directly relevant to cryoprotection. We 
show that DMSO causes an expansion of the DPPC area per lipid (in contrast to previous work 
at higher concentrations). However, it caused compression for POPC, and had little effect for 
POPE or DOPC. As most previous studies have involved only DPPC, this highlights the 
importance of studying different lipid types as these may have a significant effect on the 
interactions. We show that both ethylene glycol and glycerol cause a small expansion of the 
monolayer at fixed pressure, implying that they insert into the headgroup regions, regardless 
of lipid species, and consistent with their ability to penetrate membranes. By contrast, 
dimethylformamide causes monolayer compression for all lipid species, implying it dehydrates 
the lipid head groups. Membrane insertion experiments at physiological values of lateral 
pressure highlight that DPPC is the most difficult lipid to penetrate, implying that the 
penetrating action of cryoprotectants may only occur for unsaturated phospholipids. Thus 
extrapolations of results based solely on the DPPC need to be made with care. 
 
1 Introduction 
Cryopreservation is a viable option for the long-term storage of biological material. In 
cryopreservation, samples are stored in a vitrified state at liquid nitrogen temperatures (-196 
°C). One requirement of a successful cryopreservation protocol is an effective cryoprotective 
agent (CPA). CPAs reduce cellular damage by limiting the formation of intra- and extra-
cellular ice, minimizing cell dehydration, and inhibiting membrane phase changes 1-5. 
When a cell suspension is frozen, ice tends to form external to the cells. Solutes are excluded 
from the ice structure, which leads to an increase in the extra-cellular solute concentration, 
resulting in cell shrinkage due to the efflux of water via osmosis 5. Thus, the formation of ice 
removes liquid water – ie, it causes dehydration, which can damage cell membranes 1,6. By 
contrast, if a cell suspension is cooled rapidly, cells become supercooled, leading to the 
formation of intracellular ice, which is almost always lethal to cells 7. Thus, optimal 
cryopreservation usually involves cooling at an intermediate rate, to avoid the formation of 
*Manuscript
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intracellular ice, and limit freeze-induced dehydration. If cells can be cooled below the glass 
transition, then further growth of ice is inhibited, and biochemical processes effectively cease. 
The addition of penetrating CPAs is generally essential for successful cryopreservation. CPAs 
need to have the following properties: they should depress the equilibrium freezing point and 
encourage supercooling; they should have a relatively high glass transition temperature; and 
they must permeate cell membranes so that intracellular vitrification can be achieved 3,5. The 
proposed mechanisms of action and toxicity of a range of CPAs, are discussed in the literature 
8,9. Several studies have been carried out to understand the membrane protection effects of 
natural CPAs such as sugars, especially disaccharides, and the mechanisms are becoming 
clearer 6,10-13. The mechanisms of action of penetrating cryoprotectants have been less widely 
studied, with the exception of dimethyl sulphoxide (DMSO) and glycerol 14-21. However, these 
molecules are toxic to cells and cryopreservation involves balancing these two effects 5. Other 
classes of potential penetrating CPAs include sulfoxides, alcohols, amides and imides 22,23, 
including dimethyl formamide (DMF) and ethylene glycol (EG). These compounds offer an 
alternative to more conventional cryoprotectants, such as DMSO and glycerol, and may have 
lower toxicity, so are also worth exploring. 
The various factors affecting membrane permeability of cells during preservation are reviewed 
in a recent study by Wolkers et al.24 The interaction of DMSO with membranes has been 
studied using a range of techniques summarized elsewhere 25. DMSO can diffuse across a lipid 
bilayer 21 and can partition within an intermembrane space to limit membrane compression by 
forming a physical barrier between lipid headgroups 4. However, DMSO has also been reported 
to dehydrate lipid membranes 26,27. Molecular Dynamics simulations show that DMSO induces 
membrane thinning and increased membrane fluidity at low concentrations and causes the 
formation of pores across the bilayer at higher concentrations 4,15-17. Schrader and co-workers 
found that DMSO reduces the repulsive forces between bilayers, whereas glycerol increases 
them 28, and proposed that the differences in hydrogen bonding capability of the two solutes 
leads DMSO to dehydrate the lipid head groups, while glycerol affects surface hydration only 
as much as it affects the bulk water properties.  
One approach to studying the interactions of molecules with biological membranes is to use 
model systems of monolayers. Lipid monolayers have been widely accepted as ideal model 
systems to mimic biological membranes (reviewed for example in 29-34) as they represent 
exactly half a bilayer. They have particular advantages in examining the interactions of 
biomolecules with lipid membranes, and have been used to study such diverse systems as 
sugars 35, cryoprotectants 36,37, proteins 29, amphiphilic drugs 31 and antimicrobial peptides 32. 
The conditions under which monolayers and bilayers may be directly compared has also been 
examined 38. The key advantage over bilayer (or multilamellar) systems is that in monolayer 
studies temperature is constant and the lateral pressure is varied – this enables us to directly 
probe interactions with water soluble molecules. By contrast the lateral pressure in lamellar 
systems can only be changed by dehydration (eg 39,40). The effects of solutes on lipid 
organization can be assessed in terms of the changes in the area per lipid molecule, phase 
transition pressures and inverse compressibility modulus values 34,41-43. These can be directly 
related to the properties of bilayers: for example, the gel and fluid phases of a bilayer are 
analogous to the liquid condensed and liquid expanded phases, respectively, of a monolayer. 
Despite the relevance of monolayer techniques, the interaction between penetrating 
cryoprotectants and lipid monolayers has not been widely studied except for some early studies 
using DMSO and glycerol. Williams and Harris 44 found that DMSO and glycerol are excluded 
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from the lipid-water interface. Bianco et al. 45 observed that the presence of glycerol modifies 
the molecular area, surface potential and thermodynamic properties of monolayers of various 
lipids. Dabkowska et al. 36 found that the presence of DMSO dehydrates the 
phosphatidylcholine headgroup. Chen and co-workers found similar effects using Vibrational 
Sum Frequency Generation (VSFG) 46 and Brewster angle microscopy (BAM) 25 and found 
that the effect of DMSO is concentration dependent. These authors suggest that DMSO-
induced condensing and caging is the molecular mechanism that may account for the enhanced 
permeability of membranes upon exposure to DMSO. 
In this paper we present the first comprehensive study of the effects of four common CPAs 
(DMSO, glycerol, ethylene glycol and dimethyl formamide) on phospholipid monolayers. We 
study four different phospholipids to determine if the headgroup or level of chain saturation 
influences the interaction. 
 
2  Materials and methods  
 
2.1 Materials 
 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) from Sigma-Aldrich Chemistry (Madrid, 
Spain), 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC), and 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine 
(POPC) from Avanti Polar Lipids (Alabaster, AL, USA) were used without further purification. 
Both of the lipids were dissolved in chloroform, PA-ACS-ISO grade, purchased from 
PANREAC (Barcelona, Spain) to a final concentration of 1mg.mL-1 and kept in the 
refrigerator. The subphase used for preparing the Langmuir films was mainly Ultrapure water 
(Milli Q®, 18.3 MΩcm resistivity). Other than water, various sub-phases such as dimethyl 
sulphoxide (DMSO), glycerol, ethylene glycol and dimethyl formamide (DMF) (all 5% v/v in 
ultrapure water) were used. All of the above chemicals, PA-ACS-ISO grade, were purchased 
from PANREAC. 
 
 
2.2 Techniques and equipment 
 
2.2.1 Experiment 1 – compression isotherms using standard Langmuir trough. 
 
Langmuir compression isotherms were carried out on a NIMA teflon trough (Nima 
Technology, Coventry, UK), model 1232D1D2 (area 1200 cm2), equipped with two movable 
barriers, and the surface pressure was measured using a pressure sensor with a Wilhelmy plate 
(10 mm × 50 mm filter paper; Whatman International, Maidstone, UK). The linear velocity of 
the barriers was 2.5 cm.min-1, which corresponds to an area change of 50 cm2.min-1 in the 
trough used. 
The trough was placed on a vibration-isolated table (Newport, Irvine, CA, USA) and enclosed 
in an environmental chamber. The resolution of surface pressure measurement was ± 0.1 mN 
m−1. In all experiments, the temperature was controlled at 22.0 ± 1◦C. In each experiment, the 
trough and barriers were cleaned twice with chloroform and once with MilliQ® quality water 
before the subphase addition. In order to ensure the cleanliness of the subphase, the following 
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procedure was implemented prior to each run: the trough area was compressed to the minimum 
surface area, and any surface contaminants were removed by aspiration until zero surface 
pressure was measured. This procedure was repeated at least 3 times prior to each 
measurement. Other than MilliQ® quality water, several different CPA sub-phases were used 
at 5% v/v (dimethyl sulphoxide (DMSO), glycerol, ethylene glycol (EG) and dimethyl 
formamide (DMF)). 5% v/v was chosen as it is a common concentration used in cryoprotective 
solutions. This is with the assumption that the slight difference in molarity won’t make much 
difference in the interaction as the molecular weights of the compounds under investigation are 
not vastly varying. 
       
       
     
        
     
 
2.2.2 Experiment 2 - insertion experiments 
 
In these experiments, the effect of inserting the CPA directly into the subphase was measured 
by the change in surface pressure of the lipid monolayer. The experiments were carried out 
using a NIMA Langmuir Film Balance equipped with a Wilhelmy plate and a small teflon 
trough that was rinsed with chloroform and ultrapure water before use. All experiments were 
performed at 22±1ºC. 
For these experiments, a lipid stock solution was prepared and added dropwise on the water 
subphase until the desired surface pressure was achieved. After 15 min, when equilibrium was 
reached, the desired cryoprotectant was injected into the subphase to attain a concentration of 
5% (v/v). The surface pressure changes were monitored as a function of time for 15 min. For 
the control experiment the same procedure was followed without using lipid. For each lipid, 
up to four lipid concentrations were measured (corresponding to different initial pressures). 
The change in pressure upon addition of the cryoprotectant is a direct measure of the effect of 
the cryoprotectant on the structure of the monolayer. 
 
3 Results and Discussion  
 
3.1 Surface behavior of cryoprotectants 
 
The surface activity of the cryoprotectants is measured in this section. Initially the surface 
tension, g, of the water subphase was measured and found to be 72.6 mN.m-1. CPAs were then 
added to give a final concentration of 5% by volume, and the surface tension remeasured. Table 
1 shows the measured surface tensions, and the CPA concentration in both mol.L-1, and mass 
fraction XCPA. It is seen that DMF has significant surface activity, while the other molecules 
have minimal activity.  
 
        
      
         
        
       
       
   
   
  
            
  
A 100 µL aliquot of lipid dissolved in chloroform (concentration 0.5 mg·mL-1) was spread on 
the surface of the subphase solution with a Hamilton microsyringe (Bonaduz, Switzerland). An 
equilibration time of 15 min was allowed before starting the experiment, to allow lipid 
spreading and solvent evaporation. Every Pressure-Area isotherm was repeated at least
twice, and the isotherms showed satisfactory reproducibility. As the concentration and trough 
area are known, the area per lipid molecule can be calculated.
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Table1: Surface tension of water and CPA subphases 
 
Sub-phase 
solutions (5% v/v) 
! (mN.m-1) CCPA (mol/L) XCPA  
Water 72.6   
Glycerol 74.8 0.683 0.0128 
EG 72.8 0.894 0.0167 
DMF 67 0.646 0.0121 
DMSO 72.6 0.706 0.0132 
 
3.2 Influence of cryoprotectants on lipid monolayers - Compression 
Isotherms 
 
The phase behavior can be characterized by surface pressure-area isotherms. Figure 1(a-d) 
shows the surface pressure-area isotherms of monolayers of the 4 lipids DOPC, POPE, DPPC 
and POPC on subphases consisting of water, or aqueous solutions with 5% CPA (v/v). The 
isotherms were reproducible on successive runs. The following parameters are extracted from 
these isotherms: the lift off area (where the surface pressure rises above zero); the inflection 
points (where there is a phase change); and the collapse pressure (where pressure reaches a 
maximum, and further compression leads to collapse of the monolayer). These parameters are 
provided in Table 2. 
The first thing to note from these isotherms is that each pure lipid has slightly different 
behavior, with DOPC and POPC showing continuous isotherms up to the collapse pressure, 
whereas both DPPC and POPE show inflections corresponding to a phase change. In all cases, 
the behavior is not qualitatively changed by the presence of the CPAs, though there are 
quantitative changes in the values of key parameters. 
For all lipids studied, DMF causes a significant compression, shifting the isotherms to the left, 
whereas glycerol and EG both cause an expansion. This means that at the same surface 
pressure, DMF causes a reduction in area per molecule, whereas glycerol and EG cause an 
increase in the area per molecule. A compression of the monolayer implies that the presence 
of DMF is effectively dehydrating the headgroups, forcing them closer together. By contrast, 
the behaviour of glycerol and EG implies that they are inserting between the lipids, thus 
increasing the average area per lipid molecule at fixed surface pressure. This effect of glycerol 
agrees with that reported in literature28. These different behaviors have important implications 
for the mechanisms of cryoprotection. The behavior of glycerol and EG are consistent with 
their behavior as membrane penetrating cryoprotectants - these must reside between lipids 
during the passage across the membrane, so the observed expansion is consistent with this 
behavior. The fact that this effect is fairly similar for all four lipids implies that the effect is not 
strongly dependent on lipid headgroup or chain configuration.  
 
DMSO shows different behavior. For DPPC (saturated) it causes a clear expansion, whereas 
for POPC (singly unsaturated) it induces a small compression. For POPE and DOPC, the 
presence of DMSO has little effect. How do we interpret these conflicting results? First, the 
clear expansion in the presence of DPPC implies significant DMSO penetration into the 
monolayer. For POPC on the other hand there appears to be some dehydration. For DOPC, 
there is little effect. So, it appears that DMSO has both a membrane penetration effect, and a 
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headgroup dehydration effect, which leads to subtle differences depending on the packing of 
the headgroups. We will return to this point later. Finally, we note that there is only a small 
difference between POPC and POPE, which implies only a small headgroup dependence. 
It is known that these molecules are cell permeable, and so must interact with and pass through 
the bilayer. The permeability of cells to a particular cryoprotectant is generally termed the 
cryoprotectant permeability 47, and has been observed in previous work for glycerol, EG, and 
DMSO 48 49. These papers found that glycerol has much lower permeability than DMSO and 
EG. This is interesting in the light of the isotherm results – glycerol expands the monolayer, 
and so must enter into the headgroup region. The low measured permeability implies that it 
may take a long time to cross the hydrocarbon region of the bilayer. To the best of the authors’ 
knowledge, there are no measurements of DMF cell permeability. The monolayer studies 
suggest that DMF dehydrates the headgroups as it causes a net compression. However, DMF 
has been successfully applied as a cryoprotectant (eg 22). 
 
 
 
Figure 1: Surface pressure vs. area per molecule for (a) DOPC, (b) POPC, (c) DPPC, (d) POPE 
with subphases as shown in the legend to (a). Note that the scales are different for each lipid. 
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In order to further understand these data, Figure 2 shows the calculated inverse compressibility 
modulus (Cs-1) 43,50: "#$% = 	−) *+,+-./    Eq. (1) 
for the data in figure 1. The values of Cs-1 allows one to assign the monolayer physical state 
during compression: Cs-1 values between 12.5-100 mN.m-1 correspond to the liquid expanded 
(LE) state, 100 < Cs-1 < 250 mN.m-1 corresponds to the liquid condensed (LC) state, and Cs-1 > 
250 mN.m-1 corresponds to the solid (S) state 51.  
 
 
Figure 2: Inverse compressibility modulus vs. surface pressure for the data in figure 1.  
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is 41 °C, above the working temperature of 22 °C. By contrast POPC (transition temperature 
of -2 °C) and DOPC (transition temperature of -17 °C) do not show phase transition as the 
corresponding transition temperatures are below 22 °C. 
 
For DOPC and POPC (figures 2a, b) the Cs-1 values for DMSO, EG and glycerol subphase are 
practically the same as that of water subphase until the collapse, with DMF inducing collapse 
at a slightly lower surface pressure. Interestingly, for DOPC glycerol exhibits slightly lower 
Cs-1 values at lower surface pressures (figure 2a). 
 
For DPPC (figure 2c) the Cs-1 values of the CPA and water subphases shows a similar value 
until the inflection (~8 mN.m-1). Above the inflection, there is a notable influence of the CPA 
subphases, with Cs-1 values for DMSO and glycerol significantly lower than that of the water 
subphase, whereas the EG subphase shows higher values of Cs-1 than water subphase. 
 
Finally, for POPE (figure 2d), DMSO shows similar Cs-1 values to that of water. Glycerol 
exhibits lower values at low surface pressures, whereas DMF shows a significantly lower 
transition. 
 
The key parameters extracted from Figures 1 and 2 are summarized in table 2 and discussed 
here. DOPC (Fig 1a, 2a) shows a lift off area of 118.7 Å2/molecule, with a liquid expanded 
(LE) state until the collapse (area ~58.7 Å2/molecule, P ~45.4 mN.m-1, Cs-1max = 108 mN.m-
1). Similar behavior was observed for POPC (Fig 1b, 2b) where the lift-off is at 102.5 
Å2/molecule, with a LE state until 50.1 mN.m-1 (Cs-1max = 118.2 mN.m-1). 
 
The DPPC isotherm (Fig 1c, 2c) behaves very differently. After the lift-off at ~95.5 
Å2/molecule, it exhibits LE state until 6.4 mN.m-1, then there is a marked inflection followed 
by a regular increase in surface pressure corresponding to a Liquid condensed state (LC), and 
finally a collapse at ~59.9 mN.m-1. Similarly, the POPE monolayer on pure water (Fig 1d, 2d) 
shows several phases such as the liquid expanded (LE1) state but with a maximum Cs-1 value 
around 118 mN.m-1 at P ~ 32.3 mN.m-1, which is followed by a phase transition to what is 
either another liquid expanded (LE2) state, or to a liquid condensed state (LC) till the collapse 
at P  ~ 51.1 mN.m-1 - the proximity between the inflection and the collapse do not permit a 
unique determination of monolayer state in this region. 
 
Table 2: Parameters extracted from figures 1 & 2: lift off area (A0), collapse area (Ac), collapse 
pressure (P c), Cs-1 and P in the maximum of Cs-1 (Cs-1max, P max).  
Lipids/ Subphase A0 (Å2/molecule) Ac(Å2/molecule) P c (mN.m-1) Cs-1max (mN.m-1) P max (mN.m-1) 
DOPC 118.7 58.7 45.4 108 39.5 
    -Glycerol 142 63.3 45.9 108 43.1 
            -EG 121.2 63.3 45.9 113 41.8 
            -DMF 108.5 58.2 38.3 103 33.8 
  -DMSO 117.7 60.5 43.4 106 41.4 
POPC 102.5 50.1 49.0 118.2 42.4 
    -Glycerol 114.7 54.8 47.7 119 36.7 
            -EG 108.0 55.7 44.9 116 40.2 
-DMF 85.7 46.2 40.9 117 36.7 
9 
 
   -DMSO 97.5 50.5 45.6 121 42.0 
DPPC 95.5 36.1 59.9 29.3/233 6.4/41.1 
     -Glycerol 107.5 39.3 62.9 32.4/211 7.2/44.1 
            -EG 100.5 39.9 60.7 29.2/247 6.3/41.8 
-DMF 72.4 30.7 57.3 20.5/216 2.2/35.9 
   -DMSO 102.5 38.6 59.8 29.3/174 4.6/41.3 
POPE 92.0 38.2 51.1 118/106 32.3/45.9 
     -Glycerol 114.3 36.5 53.5 112/86.7 32.2/46.7 
            -EG 98.5 41.3 48.9 124/84.1 31.6/44.3 
-DMF 78.6 35.8 46.1 106/127 25.6/38.1 
  -DMSO 90.4 39.2 49.6 116/106 31.3/43.5 
 
We now turn to the effects of the CPAs on the lipid monolayer behavior. Looking first at the 
different headgroups (POPC vs POPE) it can be observed that each of CPAs induces similar 
changes in the isotherms and compressibility moduli for the two lipids – in other words, there 
are no significant effects which are specific to the lipid headgroup. As most previous studies 
have only been carried out on PC headgroups, this is an important finding. 
 
Considering now the individual CPAs, it is observed that the compounds with hydroxyl groups 
(glycerol and EG) cause as expansion of the monolayer across the whole pressure range for all 
four lipids, but with no significant effect on the collapse or transition surface pressures, as 
evidenced by the similarity of the Cs-1 plots. Glycerol, with 3 hydroxyl groups, causes a slightly 
greater expansion of the monolayer than EG, with 2 hydroxyl groups. 
 
The CPA that shows the largest effect is DMF, which induces a compression for all four lipids 
and also causes significant reductions in the collapse surface pressures and transition surface 
pressures - this decrease in the pc may be related in part to the small surface-active character 
of DMF, as it competes with the lipid at the interface. 
 
Finally, DMSO has almost no effect on the position of the isotherms for DOPC, POPC or POPE 
except for a slightly lower collapse surface pressure and/or transition surface pressure. 
Similarly, there is little effect on the Cs-1 plots for these lipids. By contrast, DMSO has a 
significant effect on the fully saturated lipid DPPC (Fig 1c & 2c) – the presence of DMSO 
shifts the isotherm to the right ie it provokes an area increase over the whole range. Both the 
lift off area and the area of the transition from LE to LC are significantly higher with DMSO 
than for the pure DPPC lipid. However, the cryoprotectant effects follow the same trends 
(figure 1C) both below and above the transition from liquid expanded to liquid condensed states 
(analogous to the fluid and gel states in a bilayer). This implies that headgroup interactions 
dominate over chain packing effects. 
 
 
3.3 Insertion experiments 
The insertion ability of CPAs into the lipid monolayers was monitored by measuring the 
variation in surface pressure, ΔP, as a function of the initial surface pressure. The results are 
shown in Figure 3 (a-d). For all lipids and all CPAs, it is observed that the change in pressure 
upon insertion, ΔP, decreases linearly as the initial surface pressure Pi is increased. This is not 
surprising - higher initial surface pressure means lower area per lipid, and therefore less room 
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for the CPAs to insert between the lipids. However, although the CPAs follow the same trend, 
there are significant quantitative differences, with the slope and ΔP values generally higher for 
DMF, and to a lesser extent glycerol. 
In order to examine these differences, linear fits to the data yield two parameters, the slope and 
the extrapolation to ΔP = 0, called the Maximum insertion pressure (MIP). According to the 
treatment of Calvez et al.,52 (eq 2), the slope is (a-1) where a is called the “synergy factor”. 
Values of a and MIP are given in Table 3. 
 
 
 
Table 3: Values of the Maximum Insertion Pressure (MIP) and the synergy factor (a) for 
the data in figure 3. 
LIPIDS  
 
CPAs 
DPPC POPC DOPC POPE 
MIP a MIP a MIP a MIP a 
Glycerol 12.5 0.70 25.7 0.84 33.5 0.78 29.1 0.79 
EG 17.5 0.85 25.8 0.91 26.7 0.94 21.8 0.90 
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DMF 23.6 0.26 43.5 0.48 71.9 0.79 40.6 0.62 
DMSO 9.6 0.72 22.5 0.86 27.2 0.92 18.5 0.87 
In all cases a > 0, which corresponds to favorable conditions for molecule monolayer binding, 
with higher values indicating more favorable binding of the CPA into the phospholipid 
monolayer. A number of trends can be identified from the table. First, for all lipids DMF has 
the highest MIP, and with the exception of DOPC the lowest value of a. The MIP is the 
maximum surface pressure, beyond which the molecules cannot insert into the monolayer (ie 
they would be squeezed out at surface pressures higher than this). Clearly DMF can remain 
within the monolayer to higher surface pressures. Conversely, the fact that DMF has the highest 
slope means that changes in surface pressure have a larger effect on the insertion.  
The results shown in Table 3 are instructive for comparing the different lipids. Clearly the MIP 
is lower for DPPC than the other lipids – this makes sense given that DPPC has saturated 
chains, and a smaller inherent area per molecule, attaining an LC state. Comparing the MIP 
and values of a for POPC and POPE, which only differ in the headgroup, shows relatively 
small effects, as also seen in figures 3 b, d. The largest difference is for DMF, where the slope 
is significantly larger for POPC (ie the values of a are lower) – this means small increases in 
surface pressure excludes DMF more strongly for POPC than POPE. 
For the unsaturated lipids, glycerol, EG and DMSO have similar parameters. However, for 
DPPC, the MIP is lowest for DMSO, then glycerol. Clearly the reduced area per lipid due to 
the saturated chains has a role in excluding these molecules. 
Considering physiological values of lateral pressure (around 33 mN.m-1), and looking at the 
MIP values, it is seen that EG and DMSO do not penetrate the phospholipid monolayers of 
DOPC, glycerol is at the limit, and only DMF clearly penetrates. For POPC and POPE only 
DMF penetrates at the physiological values of lateral pressure, and for DPPC none of the 
studied CPAs penetrate at the physiological values of lateral pressure. These results agree with 
Williams and Harris 27 who reported that DMSO and glycerol are excluded from the lipid-water 
interface. 
From these results it is seen that, in general, DPPC is the most difficult to penetrate due to its 
rigidity and compactness (no unsaturation in the acyl chains), while DOPC is, in general, the 
most facile to penetrate due to its lower rigidity and compactness (two double bonds in the acyl 
chains). Consequently, penetration of CPAs needs the presence of phospholipids with 
unsaturation, as is commonly the case in natural membranes. 
 
4 Discussion 
 
There have been relatively few studies of the effects of artificial cryoprotectants on monolayer 
isotherms, and most studies that exist have concentrated on DMSO and DPPC. Both Krasteva 
et al. 37 and Chen et al. 25,46 found that DMSO compresses DPPC isotherms. This effect is the 
opposite of that found in the current study, where DMSO was observed to expand the DPPC 
monolayer slightly. Those previous studies used higher concentrations than here, and Chen et 
al., noted a significant concentration dependence, which may explain the differences observed 
in the present study. Both studies concluded that DMSO leads to lipid dehydration. Recently, 
Dabkowska et al. 36 performed Neutron reflectivity on DPPC monolayers in the presence of 
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DMSO, and did not find a significant effect on the surface pressure, but found strong evidence 
to support the idea of that at high concentrations, DMSO dehydrates the headgroups by 
displacing water molecules bound to the choline group. Clearly concentration is a key factor – 
the concentrations chosen for the present study are relevant for cryopreservation.  
 
It is clear that the effects of DMSO are subtle and concentration dependent – the variability 
seen for the effect of DMSO on the different lipids highlights this. At the concentration studied 
here, DMSO caused expansion for DPPC, compression for POPC, and had little effect for 
POPE or DOPC. Clearly further work is needed to understand these effects. 
 
The authors are aware of no previous studies of the effects of glycerol, EG or DMF on 
phospholipid monolayers. However, while there are no monolayer studies, computer 
simulations studying the interactions of CPAs on bilayers can provide useful information, as 
the technique allows for the detailed study of the location of the molecules near the headgroups. 
Sum et al 53 found that DMSO penetrates more deeply into the bilayer than water – indeed they 
found that the DMSO sequesters beneath the headgroup, rather than interacting directly with 
the polar groups, leading to an increase in area per headgroup. Due to the strong DMSO-water 
interaction they also found that DMSO dehydrates the headgroups. 
 
Malajazuck et al. 4 examined the effects of DMSO, glycerol and ethylene glycol on DPPC in 
the fluid phase. They found that each solvent induced lateral expansion of the membrane, 
consistent with the results found here. These simulations found that EG and glycerol induced 
less expansion than DMSO, contrary to what was found in this study. Again, the simulation 
trends were observed for much higher CPA concentrations than are used here, so the 
differences may be due to the concentration. 
 
 
5 Conclusions 
 
The influence of four common CPAs (DMSO, glycerol, EG and DMF) on monolayers of four 
common phospholipids (DPPC, POPC, DOPC and POPE), have been studied using 
compression surface pressure-area isotherms and insertion experiments. The CPA 
concentrations were chosen to be directly relevant to cryoprotection. To the best of the authors’ 
knowledge, there has no previous studies of the effects of glycerol, EG or DMF on 
phospholipid monolayers although they are widely used as membrane penetrating 
cryoprotectants. These are also the first membrane insertion experiments reported for these 
molecules. 
 
The main conclusions from this study are: 
 
The effects of DMSO are subtle and concentration dependent – the variability observed for the 
effect of DMSO on the different lipids highlights this. At the concentration studied here (of 
relevance to cryopreservation), DMSO caused an expansion of the DPPC area per lipid. This 
is in contrast to previous studies from Krasteva et al. 37 and Chen et al. 25,46, which reported 
compression. However, those studies used higher CPA concentrations, so this highlights the 
importance of understanding concentration dependent effects, and of studying concentrations 
relevant to the application (in this case cryopreservation). 
 
The effects of DMSO are strongly dependent on the lipid species – while DMSO caused 
expansion for DPPC (in both the liquid expanded and condensed phases), it caused 
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compression for POPC, and had little effect for POPE or DOPC. As most previous studies have 
involved only DPPC, this highlights the importance of studying different lipid types as these 
may have a significant effect on the interactions. 
 
This study showed that both EG and glycerol cause a small expansion of the monolayer at fixed 
pressure, implying that they insert into the headgroup regions. This effect is similar for all lipid 
species studied and is consistent with their ability to penetrate membranes. 
 
By contrast, DMF causes monolayer compression for all lipid species, implying it dehydrates 
the lipid head groups. This is perhaps related to the small inherent surface activity of DMF, 
which reduced the surface tension by 5.6 mN.m-1 compared to pure water. This surface activity 
may also be responsible for the fact that DMF had the highest maximum insertion pressure (ie 
showed the strongest affinity to stay in the monolayer). DMF has been used as a cryoprotectant, 
but there have been very few studies of its lipid interactions – clearly more work needs to be 
done here. 
 
However, all four CPAs are known to penetrate into cells. Understanding the mechanisms of 
this penetration in more detail is the goal of future work using neutron membrane diffraction 
in lamellar systems 2,11,12. 
 
The insertion studies showed that the phospholipid species has a notable impact on the 
interactions with the CPAs. DPPC was the most difficult to penetrate (as expected due to the 
tighter chain packing) while DOPC was the most facile. These studies imply that at 
physiological values of lateral pressure, the penetrating action of CPAs may only occur for 
unsaturated phospholipids (as are present in natural membranes). Thus, extrapolations of 
results based solely on the saturated lipid DPPC need to be made with care. 
 
While previous studies have been conducted overwhelmingly with model membranes (often 
DPPC) it is clear that the lipid species has a significant effect – more studies are needed with 
membrane models which more closely mimic biological membranes. In particular, almost all 
previous studies have been conducted with zwitterionic (neutral) lipids. However, one might 
expect charged lipids (such as phosphatidylinositol) to play a significant role in interactions 
with polarizable molecules such as CPAs, and effects of salts and pH may also play a 
significant role. Further studies of such systems are clearly needed. 
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A series of eight n-octyl (thio)glycosides (1a,b–4a,b) with D-glucose or D-galactose-configured head groups and varying
anomeric configuration were synthesized and evaluated for glass transition behaviour, membrane permeability, and ice
recrystallization inhibition (IRI) activity. Of these, n-octyl b-D-glucopyranoside (2b) exhibited a high glass transition
temperatures (Tg), both as a neat sample and 20 wt-% aqueous solution. Membrane permeability studies of this compound
revealed cellular uptake to concentrations relevant to the inhibition of intracellular ice formation, thus presenting a
promising lead candidate for further biophysical and cryopreservation studies. Compounds were also evaluated as ice
recrystallization inhibitors; however, no detectable activity was observed for the newly tested compounds.
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Cryopreservation is a technique that utilizes ultralow tem-
peratures for the long-term preservation and subsequent re-use
of structurally intact and biochemically viable cells.[1] How-
ever, unprotected freezing is almost universally lethal and
requires the use of chemical additives, or cryoprotective agents
(CPAs), to preserve life at the very low temperatures required—
ideally well below !1008C.[2] Combined with carefully opti-
mized cooling (and warming) rates, CPAs make it possible to
achieve these low temperatures without the damaging effects of
ice formation and excessive freeze-induced cell dehydration.
By increasing the overall solute concentration, CPAs can act
intracellularly or extracellularly (or both) by several known
mechanisms, including restoration of osmotic balance to avoid
freeze-induced dehydration, promotion of a glassy state
(vitrification), and the elimination of intracellular ice formation
(IIF) – a major cause of cryoinjury.[3]
Since the first use of glycerol as a CPA in 1949,[4] cryo-
preservation technologies utilizing CPAs have evolved to the
point where it is now possible to successfully preserve animal
and plant cells and tissues, including red and white blood cells,
plant seeds and leaf tips, some stem cells, and cancer cells.[5]
However, despite decades of research, serious problems asso-
ciated with the toxicity of conventional CPAs persist, which
has limited their routine use to all but a few cell and tissue
types. Widely used cell-penetrating CPAs such as dimethyl
sulfoxide (DMSO) and glycerol are toxic to many cell types
and can disrupt lipid membranes at high concentrations.[2,5]
Successful freezing protocols using CPAs are highly cell-
dependent and require a careful balance between cooling rates
and CPA concentration and exposure time. The toxicity of
commonly used CPAs also requires rapid thawing followed by
time-consuming and expensive removal before re-use of the
sample, which is less than ideal for critical applications
including reproductive technologies, stem cell therapies, organ
and tissue transplantation, and preservation of endangered
plant and animal species. Most conventional CPAs also do
not inhibit damaging ice recrystallization (the growth of larger
ice crystals at the expense of smaller ones) that often occurs
during thawing cycles. New, non-toxic CPAs that can penetrate
and access all cellular compartments, promote vitrification,
and which are capable of inhibiting ice recrystallization are
highly sought after in several research fields and industries
including biotechnology, regenerative medicine, food technol-
ogy, and conservation. However, despite decades of research
and the clear benefit of these CPAs to humankind, no such
breakthrough has eventuated.
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Many cold-tolerant and freeze-avoiding organisms residing
in the Earth’s temperate and polar regions produce natural CPAs
and macromolecular antifreezes as key adaptations that enable
survival in these harsh climates.[6] For example, soluble sugars
such as sucrose, trehalose, and raffinose play essential roles in
reducing cold stress and improving cold tolerance in several
plant, fungal, and insect species.[7] These polyhydric molecules
also restore osmotic equilibrium during freezing, thus alleviat-
ing freeze-induced dehydration and cell death, and stabilize
lipid membranes during freeze-induced dehydration by retain-
ing additional water, and hindering the close approach of
membranes.[8,9] Glycolipids of natural and synthetic origin have
been shown to promote thermal hysteresis activity in several
cold-tolerant organisms,[10] as well as stabilize proteins[11] and
artificial vesicles during freeze-drying, presumably through
hydration of phospholipid head groups within the lipid
bilayer.[12] Owing to their low toxicity, promising ice growth
inhibition activity, and high glass transition temperatures in
experimental systems, carbohydrates have emerged as attractive
candidates for the development of new CPAs. Unfortunately,
owing to their high polarity, soluble sugars alone are poor
cryoprotectants as they are generally not membrane permeable,
and so are incapable of inhibiting IIF.
An alternative, and extremely promising, approach aimed at
improving the membrane permeability of soluble sugars is to
enhance lipophilicity by modifying the carbohydrate scaffold
with hydrophobic groups.[13–15] In their previous work, Toner
and coworkers reported the synthesis and membrane permeabil-
ity properties of somemodified trehalose derivatives possessing
enzyme-cleavable acetate esters.[15] Increasing the intracellular
concentration of soluble sugars has also been shown to enhance
the survival and viability of mammalian cells post thaw.[16]
Recent work from our laboratory, along with Ben and collea-
gues, have also demonstrated the significant ice recrystallization
inhibition (IRI) activity of amphiphilic carbohydrate derivatives
including surfactants and hydrogelators,[17] azobenzene analo-
gues,[18,19] and aryl glycosides.[20] N-octyl (thio)glycosides are
non-ionic surfactants that have emerged as viable alternatives to
ionic surfactants from petrochemical origin due to their clinical
mildness, low toxicity, and performance. As such, they have
seen widespread use in pharmaceutical and consumer health
care industries, as well as in biochemical research.[21] Non-
ionic, carbohydrate-based surfactants have emerged as promis-
ing CPAs given their remarkably high, sub-zero glass transition
temperatures and ability to inhibit eutectic formation in NaCl/
H2O mixtures.
[22] Despite this, their viability as a new class of
penetrating CPAs is yet to be fully explored. Based on these
earlier observations and inspired by the natural antifreeze and
cryoprotective activity of glycolipids, we were interested in
exploring the potential of n-octyl (thio)glycosides as a novel and
accessible class of penetrating CPA. We reasoned that, given
their low toxicity, promising thermal properties, and hydropho-
bicity, these molecules could induce glass transitions at rela-
tively high temperatures and display sufficient membrane
permeability to access intracellular compartments and eliminate
IIF. Herein, we report the glass transition properties, membrane
permeability, and IRI activity of eight n-octyl (thio)glycosides
(1a, b–4a, b). These (thio)glycosides possess a variable mono-
saccharide head group (glucose or galactose) linked to an
n-octyl tail group via an oxygen or sulfur atom with either a
or b anomeric configuration. We demonstrate the high depen-
dence of the glass transition behaviour on the molecular struc-
ture of these surfactants, membrane permeability, and IRI
activity, which are preliminary steps in their overall examina-
tion as potential cryoprotectants.
In order to understand the effect of the monosaccharide head
group and anomeric linkage on the cryoprotective properties of
the surfactants, our studies commenced with the synthesis of
eight n-octyl (thio)glycosides 1a, b–4a, b, each possessing a
glucose or galactose head group linked to an n-octyl tail groupvia
an oxygen or sulfur atom at the anomeric centre (Fig. 1).
Optically pure surfactants 1a, b–4a, b were synthesized
using known and adapted literature procedures employing
Lewis acid (BF3.EtO2)-promoted glycosylation of 1-octanol or
1-octanethiol with commercial b-D-galactose pentaacetate or
b-D-glucose pentaacetate as donors (see SupplementaryMaterial
for details).[23,24] Protected (thio)glycosides were afforded in
good yields as anomeric mixtures (2 : 1 to 2 : 3 a/b selectivity),
which were resolved using flash silica gel chromatography.
Optically pure per-O-acetylated n-octyl (thio)glycosides were
then smoothly deprotected under standard Zemple´n conditions to
give target compounds in quantitative yields.
We next investigated the vitrification behaviour of these
n-octyl (thio)glycosides using differential scanning calorimetry
(DSC), both as neat samples and as 20 wt-% aqueous solutions
(0.68M for 1a, b and 2a, b; 0.65M for 3 a, b and 4 a, b)
relevant to cryopreservation. The glass transition behaviour (Tg)
of octyl b-D-glucopyranoside (2b) and octyl b-D-thioglucopyr-
anoside (4b) has been previously investigated by Ogawa
and coworkers, with relatively high Tg values observed on
heating and no ice formation observed at concentrations above
,80 wt-% in water.[22] Wewere thus interested in observing the
glass transition temperatures of surfactants 1–4 possessing
alternative head groups and anomeric configuration at concen-
trations and temperatures most relevant to cryopreservation. For
DSC thermograms of neat surfactants, samples (5–10mg) were
hermetically sealed in aluminium sample pans and cycled
between þ1508C and !508C at a rate of 108Cmin!1, with
1-min equilibration times at the endpoints (Fig. 2a). The thermal
values for neat surfactants are summarized in Table 1. Of the
eight samples studied, only thioglucosides 4a and 4b did not
show any glass transition behaviour as anhydrous solids on
warming from !1008C to 258C (see Fig. S1, Supplementary
Material). The remaining soluble samples showed Tg values
between 08C and !158C, which are clearly visible as step-like
inflections in the thermograms, as previously reported for some
n-octyl glycosides.[25,26] However, the Tg values for the neat
samples are slightly lower than that previously reported, which
may be attributable to the adsorption of trace water and the
possibility of hemihydrate crystal formation.[27]
Galactoside 1a, thiogalactoside 3b, and thioglucosides 4a,b
unfortunately were only partially soluble and so could not be
assessed as a 20 wt-% binary system with water. DSC thermo-
grams of the four soluble surfactants (1b, 2a, 2b, and 3a) were
recorded by warming samples from!1208C to 258C at a rate of
58Cmin!1, with 1-min equilibration time, and the results are
shown in Fig. 2b. On cooling, large exothermic peaks could be
seen between !158C and !258C, thus indicating ice crystalli-
zation (see Fig. S2, Supplementary Material). Following glass
melting in the warming run, the supercooled solution then
underwent freezing, as shown by a positive peak. The ice
subsequently melted as it reached the freezing point, as indi-
cated by the large endothermic peaks. The melting temperature,
Tm, can thus be defined at the end of ice melting for most of
the solutions studied. Encouragingly, all soluble n-octyl
(thio)glycosides displayed Tg values above !608C, which are
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higher than the commonly used CPA, DMSO (Tg approximately
!1308C; see Fig. 2). Of these, n-octyl b-D-glucoside 2b showed
particular promise, with high Tg values, both as a neat sample
(Tg !4.978C) and in solution (Tg !488C), which is in good
agreement with previous thermal studies on this compound.[28]
For 2a and 3a, there were small changes in the baseline that may
correspond to Tg, but could also represent liquid crystalline
transitions that could not be confirmed based on current data.
They are indicated by the small arrows (Fig. 2b) and values with
superscript letter ‘A’ in Table 1. In the case of 2a, the fact that
there is a clear devitrification peak indicates that glass melting
must have occurred; however, the value of Tg is unclear. The
positive peaks at temperatures just below ice melting could be
due to ice recrystallization, but may also be attributed to
crystallization of synthesized glycosides, as recently shown by
Ogawa and coworkers.[29] For the purpose of the present study,
we are only interested in the glass transition properties, and so
this was not pursued further.
Clear devitrification peaks are observed for 1b, 2a, and 2b,
which must be preceded by glass melting. The glass transitions
are clear for 1b and 2b, but indistinct for 2a, where two possible
weak transitions were identified (marked by superscript letter
‘A’). 3a shows no devitrification peak, with a weak possible
glass transition just before melting (marked by superscript letter
‘A’). The thermal values for aqueous surfactants are summa-
rized in Table 1.
Having established the thermal properties of the n-octyl
(thio)glycosides, the next stage of our study focussed on the
cell permeability of the four molecules possessing promising
Tg values and high solubility in water and RPMI cell media
(1b, 2b, 2a, 3a). For the most commonly used CPA, DMSO,
the cryobiologically relevant concentrations are 5 and
10% by volume, which is equivalent to 0.65 and 1.3M
respectively. A cell perfusion permeability study was con-
ducted using 0.65M solutions of each compound using the
THP-1 human leukemia monocytic cell line. Although this
method can provide detailed concentration-dependent cell
permeability data with high temporal sensitivity, it does have
intrinsic limitations based on compatible cell types (spherical
only), as well as difficulties associated with maintaining the
concentration of the CPA used and the position of the settled
cell(s) during perfusion within the conventional well plate. As
a result, all experiments were repeated several times to obtain
consistent results. At this concentration, a-glucoside 2a and
a-thiogalactoside 3a were not permeable and displayed some
cytotoxicity (cells started bulging towards the sides with lysis
occurring within 1min). In contrast, b-D-octyl galactoside 1b
and glucoside 2b showed good shrink–swell behaviour,
which indicates membrane permeability (Fig. 3). Unfortu-
nately, these compounds also resulted in some cell damage at
the end of the incubation period (,1min) as shown from
visible cell lysis in the micrographs (Fig. 3a). However, it is
not at all surprising to see some cell membrane damage after
prolonged exposure given the strong surfactant properties of
these molecules, particularly at concentrations well above
their reported critical micelle concentration (CMC) values.[30]
To test the concentration dependence of this cytotoxicity, the
cell perfusion assay was then repeated at 0.33M. Encourag-
ingly, at this lower concentration, good shrink–swell behav-
iour was observed for both n-octyl b-D-glycosides 1b and 2b,
similar to that observed at 0.65M concentration but with little
observed membrane damage, particularly for the glucoside
2b. Perfusion of glucoside 2b resulted in total cell lysis only
after ,230 s of incubation, with evidence of membrane
damage occurring from ,160 s of contact time, as shown
from the blurring of the cell image in Fig. 3c. Interestingly, in
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Fig. 1. Chemical structures of n-octyl (thio)glycosides 1–4 used in this study.
Sugar Surfactants as Potential Cryoprotectants C
contrast to the glucoside, b-D-galactoside 1b showed
evidence of cell damage within 1min of incubation, with
total cell lysis observed within ,166 s (Fig. 3b). Unlike the
b-D-glycosides 1b and 2b, the corresponding a-glucoside 2a
and thiogalactoside 3a were not membrane-permeable and
displayed significant cytotoxicity at both 0.65 and 0.33M
concentrations.
Fig. 4 shows the normalized cell volume as a function of time
for 1b and 2b (at 0.33M). For both samples, the normalized
volume decreases to ,80% of the initial volume (V0) after
,45 s. For comparison, in the presence of 0.65M DMSO, the
cells shrink to,65% V0 in,25 s. Overall, provided that long-
term contact with cells is avoided, b-D-glycosides 1b and 2b
show promising membrane permeability at concentrations rele-
vant to cryopreservation.
Ice recrystallization is a thermodynamic phenomenon
whereby larger ice crystals grow at the expense of smaller ones
and is a significant cause of cell damage during cryopreserva-
tion.[31] The IRI activity of carbohydrate-based surfactants has
been previously determined at concentrations up to 44mM,with
the glucoside 2b displaying weak to moderate IRI activity,
whereas the galactoside 1b exhibited potent IRI activity.[17] The
IRI activity of amphiphilic carbohydrates is highly sensitive to
molecular structure, with the polarity, hydration, and absolute
configuration of the carbohydrate head group, as well as tail
group hydrophobicity and substitution all regarded as important
determinants for inducing potent IRI activity.[17,19,32] Previous
studies have also demonstrated the importance of tail-group
hydrophobicity of amino acid derivatives[33] and amphiphilic
block copolymers[34] for tuning potent IRI activity. Interest-
ingly, although earlier work has evaluated the effect of changing
the structure of the head and tail groups of carbohydrate
surfactants on IRI activity, an investigation into the effect
of the anomeric configuration and linkage type (e.g. O- and
S-glycoside) for carbohydrate-based surfactants has yet to be
conducted.
In order to evaluate the effect of substituting the oxygen atom
at the anomeric centre with a more hydrophobic sulfur atom, the
IRI activity of thioglycosides 3a, b and 4a, b was determined
using an established splat-cooling assay up to 5.5mM concen-
tration, which represents the upper solubility limit for these
compounds in PBS buffer (see Fig. S3, Supplementary
Material).[35] Unfortunately, unlike the n-octyl glycosides pre-
viously reported, the analogous thioglycosides used in the
present study did not display any significant IRI activity.
Curiously, although the O-glycoside 1b displayed weak to
moderate IRI activity at 1mM concentration (,80% mean
grain size relative to PBS),[17] replacement with a sulfur atom
to give thioglycoside 3b resulted in complete loss of activity
(100% mean grain size relative to PBS), albeit at a lower
concentration (0.5mM). This loss in IRI activity compared with
previously described O-glycosides is perplexing; however, it
may be due to freeze-induced crystallization or precipitation of
compounds within the assay. Alternatively, substitution of
oxygen for sulfur may have resulted in a decrease in head group
polarity, with a concomitant decrease in its hydration index, thus
lowering IRI activity.[36] Regardless of mechanism, these com-
pounds were not IRI-active and this mode of action cannot
account for their potential cryoprotective effect.
In conclusion, we have reported the glass transition behav-
iour, membrane permeability, and IRI activity of a series of
n-octyl (thio)glycosides (1a, b–4a, b). Of all soluble samples
studied, n-octyl b-D-glucopyranoside 2b exhibited high
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Fig. 2. DSC warming thermograms for (a) neat, and (b) 20 wt-% aqueous
samples for the samples indicated in the captions. Only the regions of interest
are shown. The inset in (b) shows a complete representative scan for one the
samples, 2b, showing the large icemelting (negative) peak. Scans have been
vertically offset for clarity. Glass transitions (Tg) are indicated by bold
arrowheads. Small arrows indicate regions with small changes, which may
be glass transitions.
Table 1. Tg values of water-soluble n-octyl (thio)glycosides 1b, 2a, 2b,
and 3a
Sample name Samples,
neat, Tg [8C]
Samples, 20 wt-%, Tg [8C]
1b !9.99 !55.6, devitrification peak
2a !11.93 !46.0A, !58.9A, devitrification peak
2b !4.97 !48.0, devitrification peak
3a !9.73 !22.1A
AValues may indicate a Tg or liquid crystalline transitions.
D R. Raju et al.
sub-zero Tg values from the DSC thermograms, both as a neat
sample and as a 20wt-% aqueous solution. Using a cell perfusion
permeability assay against human THP-1 cells, glucoside 2b
(0.33M) also exhibited favourable shrink–swell behaviour simi-
lar to DMSO. Encouragingly, we observed promising cell per-
meability with little cytotoxicity, provided the exposure time is
kept within ,160s, a reasonable timeframe for exposure before
cryopreservation. The IRI activity of thioglycosides 3a,b and 4a,
bwas also evaluated and comparedwith previously publishedO-
glycosides 1b and 2b. Substitution of the anomeric oxygenwith a
sulfur atom resulted in significantly lower IRI activity, which
may be a result of the increased hydrophobicity and decreased
hydration of the carbohydrate head group in thioglycosides. In
addition to the vitrification and permeability data presented
herein, glucoside 2b has also previously been shown to display
moderate IRI activity and therefore represents a promising lead
0 s 16 s 46 s
64 s 76 s 90 s
0 s 16 s 44 s
61 s 156 s 166 s
16 s 43 s0 s
64 s60 s46 s
230 s120 s 160 s
(a)
(b)
(c)
Fig. 3. Micrographs of changes in cell volume as a function of time for THP-1 cells in the presence of: (a) 0.65M n-octyl b-D-galactoside 1b; (b) 0.33M
n-octyl b-D-galactoside 1b; and (c) 0.33M n-octyl b-D-glucoside 2b. Note that there is some movement of cells between frames, so arrows indicate a cell
whose volume is measured in each frame. Where no arrow appears, the cell can no longer be identified. Scale bars¼ 10mm.
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compound for further biophysical and cryopreservation studies.
In future work, we will investigate the mechanisms of cellular
uptake for these surfactants, as well as the rational development
of new, hydrophobic carbohydrate analogues as potential CPAs
capable of promoting vitrification, eliminating IIF, and inhibiting
ice recrystallization.
Supplementary Material
General experimental information, supplementary DSC and IRI
data, and NMR data are available on the Journal’s website.
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Sugar Surfactants as Potential Cryoprotectants G
Chapter 5 
Glass transition, permeability and cryopreservation studies with 
novel potential cryoprotectants - trehalose derivatives 
 
 
  
As discussed in chapter 1, there is a need for new non-toxic CPAs that can penetrate cell 
membranes, access all cellular compartments, promote vitrification, and inhibit ice 
recrystallization. Applications include biotechnology, regenerative medicine, food technology, 
and conservation. Owing to their low toxicity, promising ice growth inhibition activity, and 
high glass transition temperatures, carbohydrates have emerged as attractive candidates for the 
development of new CPAs. Unfortunately, owing to their high polarity, soluble sugars alone 
are poor cryoprotectants as they are generally not membrane permeable, and so are incapable 
of inhibiting IIF1,2. For example, trehalose acts as a CPA in nature, where it is accumulated 
within cells. However, as an artificial CPA it cannot be used by itself as it can’t penetrate the 
cell membrane, and so the cells may suffer damage due to osmotic shock2-4. An alternative 
approach aimed at improving the membrane permeability of soluble sugars is to enhance 
lipophilicity by modifying the carbohydrate scaffold with hydrophobic groups5-7. If the 
trehalose derivatives can penetrate into the cell this can potentially lead to better 
cryoprotection. Toner and co-workers previously reported the synthesis and membrane 
permeability properties of some modified trehalose derivatives possessing enzyme-cleavable 
acetate esters6. Inspired by these earlier observations and the natural antifreeze and 
cryoprotective ability of soluble sugars such as trehalose1, this study aims to explore the 
potential of trehalose derivatives as a novel and accessible class of penetrating CPA. This 
chapter reports the glass transition behaviour and membrane permeability of various modified 
trehalose derivatives. Finally, cryopreservation trials were carried out on those compounds 
which showed high glass transition temperature and relatively good membrane permeability.  
     
Four trehalose derivatives were used for the current study, taking trehalose as a control. These 
compounds were synthesised in the lab of co-supervisor Dr. Brendan Wilkinson at University 
of New England. The trehalose derivatives were made by modifying the carbohydrate scaffold 
with hydrophobic groups such as enzyme-cleavable acetate and pivotate esters. The molecular 
structures of trehalose and the four trehalose derivatives are shown below (Fig.5.1) and 
represented as S-1, S-2, S-3, S-4 and S-5 respectively in this chapter - (S-1) D-trehalose; (S-2) 
D-trehalose(2*OAC); (S-3) D-trehalose(2*OPiv); (S-4) D-trehalose(4*OAC) and (S-5) D-
trehalose(6*OAC). 
 
5.1 Introduction
5.2 Experimental: Materials and Methods
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Fig.5.1: Molecular structures of trehalose and its derivatives 
Glass transition8-14 (vitrification) behaviour of these trehalose derivatives was investigated 
using DSC, both as neat samples and 20 wt% solutions. For the permeability studies, Poly-L-
Lysin coated cover slips were used for cell attachment and immobilization. The cell responses 
were monitored and recorded via an inverted microscope with a digital camera attached to the 
microscope. Video was recorded at 20 frames/second until osmotic equilibrium was obtained. 
In this work, all the perfusion images were captured for at least 5-10 minutes. All experiments 
were done at room temperature (~22°C). The cell lines used for the permeability and 
cryopreservation studies are Human monocytes (THP-1 cells). More details about the 
equipments, method and materials used for the study are explained in the methodology chapter 
(section 2.3). 
    
5.3.1  DSC thermograms – Phases observed on cooling and warming 
Of the five samples (trehalose and it’s four derivatives) studied here, D-trehalose-6*OAC (S-
5) was only partially soluble and was not investigated further. Fig.5.2 (A&B) represent the 
warming thermograms of the remaining samples (S-1 to S-4) in neat form and aqueous form 
respectively. The measured Tg values are given in Table 5.1.  
  
5.3 Results and Discussion
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Fig.5.2: DSC warming thermograms showing Tg of Trehalose and its derivatives: 
(A) Neat samples (B) aqueous samples, inset shows the Tg of 10 vol% DMSO for 
comparison   
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Table 5.1: Tg values of trehalose and it’s derivatives 
Sample 
No: 
Sample Name Neat samples Aqueous samples (20 wt%) 
1 S-1 -74.7 -99.0 
2 S-2 -71.8 -75.3 
3 S-3 -50.3 -86.5 
4 S-4 -64.8 -95.8 
5 S-5 -- -- 
DSC thermograms were recorded by warming the samples from -160 to +25°C at a rate of 
10°C min-1 with 1-minute equilibration times at the end points. All four samples showed glass 
transition between -40°C and -80°C in neat form which are clearly visible as step-like 
inflections in the thermograms and are indicated with arrows (see Fig.5.2 A). Similarly, for the 
20 wt% aqueous samples, the glass transitions were observed in between -70°C and -100°C 
which are also indicated by arrows (see Fig.5.2 B). The ice subsequently melts as it reaches the 
freezing point, as indicated by the large endothermic peaks. The melting temperature, Tm, can 
thus be defined at the end of ice melting for the solutions studied. The small inflections at 
temperatures just below ice melting could be due to ice recrystallization, but also may be 
attributed to the crystallization of synthesized trehalose derivatives as has been reported for 
other carbohydrate based surfactants such as glycosides15. For the purpose of the present study, 
we are only interested in the glass transition properties, and so these were not examined further.  
Encouragingly, all the soluble trehalose samples showed relatively high Tg between -100℃ 
and -40℃, which are high in comparison with the Tg of the most commonly used CPA, DMSO 
(~-130℃), which is shown in the inset to Fig.5.2B for comparison. The most promising 
candidates with very high glass transition temperatures were trehalose di pivotate and trehalose 
tetra acetate (S-3 & S-4).  
 
       
The next step was to study the cell permeability of the three trehalose derivatives which showed 
high Tg and solubility in water/RPMI cell media. As (S-1) D-trehalose is well known to be 
impermeable to cells, the samples analyzed are S-2, S-3 and S-4. Cryobiologically relevant 
concentrations of DMSO are 5% and 10% by volume which is equivalent to 0.65M and 1.3M 
respectively, so in this study, cell perfusion experiments were conducted with 0.65M solutions. 
S-2, trehalose-di acetate didn’t show any cell permeability. Fig.5.3(A, B) shows the cell volume 
excursion of THP-1 cells when perfused with 0.65M concentration of S-3 and S-4, and a graph 
of the normalised cell volume as a function of time is shown in Fig.5.4. In the inset, DMSO 
perfusion on THP-1 cells is shown for comparison. The initial volume shrinkage due to the 
water efflux takes longer (~80s) compared to DMSO(~22-29s) for both samples S-3 & S-4. 
The minimum volume attained by the cells in the shrinkage phase in the presence of S-3, 
trehalose di pivotate was 0.62V0 where V0 is the initial cell volume before CPA perfusion, 
which is similar to DMSO (0.67-0.72V0). Interestingly, not only is the volume recovery slower 
5.4 Cell permeability- shrink-swell behavior of cells
41
than for DMSO, the initial shrinkage due to water efflux is also slower. This implies that water 
permeability is directly affected by the presence of the CPA. 
 
 
Fig.5.3: THP-1 cell perfusion with the two trehalose derivatives - (A) Volume 
response of the cells to 0.65M solution of S-3, trehalose di pivotate (D-
treh(2*OPiv)), it has relatively good cell permeability leading to nice shrink-swell 
behavior (B) Volume response of the cells to 0.65M solution of S-4, trehalose tetra 
acetate (D-treh(4*OAc)) which also shows some cell permeability but with less 
swelling back to the initial cell volume. 
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Fig.5.4: Cell volume excursion during perfusion by the two trehalose derivatives. 
Inset shows the cell shrink-swell response to DMSO perfusion which is 
considerably faster. 
The perfusion method applied here has some limitations. Even though Poly-L-lysin coating 
favours cell attachment and thereby avoids cell movement while imaging, considerable care is 
needed at the time of solution addition in order to maintain focus on a single field of view and 
avoid cell dislodgement. Moreover, as this is a photomicrographic method, its measurement 
accuracy depends on the quality of captured images and accuracy of image processing. The 
method also assumes the cells are spherical when converting from a two-dimensional image to 
three-dimensional volume, which is clearly not always accurate. However, it should be noted 
that the main purpose of these measurements is a quick diagnostic tool to determine (i) whether 
or not the compound is permeable; (ii) the approximate permeation time; and (iii) the level of 
immediate toxicity. Quantitative determination of permeability is therefore not required here. 
     
The two trehalose derivatives (S-3, and S-4) which showed promising cell permeability 
characteristics were used for cryopreservation studies of THP-1 cells. Table 5.2 shows the trials 
including pure DMSO, DMSO/trehalose derivatives and trehalose derivatives alone. All 
samples were preserved for 1 week in LN. The protocol used for cryopreservation was same 
for all the samples, which is the optimized protocol for DMSO preservation (Refer chapter 
2.4). After 1 week in LN, cells were revived, and cell viability measured immediately using 
Trypan blue exclusion test16. All samples were then cultured in RPMI cell media and stored in 
the incubator for regrowing. Sub-culturing was done at 3-4 days intervals, with cell viabilities 
checked repeatedly. The results are given in Table 5.2, with cell images shown in Fig.5.5.  
 
5.5 Cryopreservation of THP-1 cells using Trehalose derivatives
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Table 5.2: Cell viabilities of the samples cryopreserved using CPAs as DMSO and 
trehalose derivatives 
 
Vials Samples Viability 
After 
revival 
4 days after sub-
culturing 
7 days after sub-
culturing 
1 Cells+ DMSO 1.3M  82% 86% 97% 
2 Cells+ DMSO 0.65M  63% 73% 95% 
3 Cells+ 0.65M S-3 25% 13% 8% 
4 Cells+ 0.65M DMSO + O.65M S-3 44% 36% 6% 
5 Cells+ 0.65M S-4  4% 1% 0% 
6 Cells+ 0.65M DMSO + 0.65M S-4 42% 30% 3% 
 
 
 
 
Fig.5.5: Cell images after 1 week of cryopreservation using DMSO and trehalose 
derivatives 
 
Cells cryopreserved with DMSO showed good viability in the tests as expected. Although the 
samples cryopreserved with trehalose showed lower viability than the DMSO preserved 
samples, the viabilities were greater than zero per cent. Samples preserved with the trehalose 
dipivotate (S-3) showed higher viability (25% after revival) than trehalose tetra acetate (S-4) 
(4%). The samples with a mixture of DMSO and S-3 or S-4 also showed good viability after 
revival. For all samples with S-3 and S-4, cell viabilities dropped after each sub culturing stage, 
though for S-3 some viability was always retained.  
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While these results are slightly disappointing, the fact that some cells still survived 
cryopreservation using trehalose derivatives as alternative CPAs shows that this approach is 
promising and is a steppingstone for further study of similar compounds as future potential 
CPAs. 
 
         
  
The cryopreservation investigations described above used the standard optimised protocol for 
DMSO cryopreservation. Given that the trehalose derivatives did show some promise, it was 
decided to determine if the cryopreservation protocol could be adjusted to achieve better 
results. For these final trials, the most promising candidate molecules was used which is, 
trehalose di pivotate. Four cryopreservation protocols P1-P4 (see chapter 2.4) were trialled and 
the results are presented in Tables 5.3-5.6. Cell images after trehalose dipivotate and DMSO 
preservations under the four different protocols are shown in Figures 5.6 & 5.7. 
 
As expected, cells cryopreserved with both 1.3 M and 0.65M DMSO (samples1 & 2) showed 
good viability and were growing nicely after sub-culturing in protocols P-1 and P-2. Viability 
of these samples were good for protocols P-3 & P-4 but not as good as protocols P-1 & P-2 
and the observed growth rates were very slow after sub-culturing. However, the viability results 
were not much promising for any of the samples cryopreserved with Trehalose dipivotate. 
Samples cryopreserved with S-3 using protocols P-1 and P-2 showed some viability (less than 
15%) but cell growth was not so promising after sub-culturing. For samples cryopreserved with 
S-3 using protocols P-3 & P-4 the viability and growth rates were very low - almost all the 
cells were found dead after sub-culturing. 
 
 
 
 
  
5.6 Cryopreservation of THP-1 cells with Trehalose di pivotate using
 different cryopreservation protocols
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Table 5.3 Cell viabilities of the samples cryopreserved using protocol P-1: Bypassing the 
first step (transferring to freezing box), otherwise keeping the protocol the same as standard 
DMSO cryopreservation protocol. 
 
Vials Samples Viability 
After revival 4 days after 
sub-culturing 
7days after sub-
culturing 
1 Cells+ DMSO 1.3M  76% 88% 97% 
2 Cells+ DMSO 0.65M  68% 86% 94% 
3 Cells+ 0.65M S-3 12% 5% 2% 
4 Cells+ 0.65M DMSO + 0.65M S-3 14% 8% 3% 
 
Table 5.4 Cell viabilities of the samples cryopreserved using protocol P-2: Bypassing the 
first step (transferring to freezing box), then directly transferring to -80ºC freezer and then 
to LN. 
 
Vials Samples Viability 
After revival 4 days after 
sub-culturing 
7days after sub-
culturing 
1 Cells+ DMSO 1.3M  76% 89% 96% 
2 Cells+ DMSO 0.65M  75% 86% 93% 
3 Cells+ 0.65M S-3 11% 3% 0% 
4 Cells+ 0.65M DMSO + 0.65M S-3 9% 5% 1% 
 
Table 5.5 Cell viabilities of the samples cryopreserved using protocol P-3: As for P-1 except 
all procedures were carried out at 4 ºC instead of room temperature. 
 
Vials Samples Viability 
After revival 4 days after 
sub-culturing 
7days after sub-
culturing 
1 Cells+ DMSO 1.3M  46% 58% 63% 
2 Cells+ DMSO 0.65M  43% 56% 58% 
3 Cells+ 0.65M S-3 3% 0% - 
4 Cells+ 0.65M DMSO + 0.65M S-3 4% 0% - 
 
 
Table 5.6 Cell viabilities of the samples cryopreserved using protocol P-4: As for P-2 except 
all procedures were carried out at 4 ºC instead of room temperature. 
 
Vials Samples Viability 
After revival 4 days after 
sub-culturing 
7days after sub-
culturing 
1 Cells+ DMSO 1.3M  43% 52% 61% 
2 Cells+ DMSO 0.65M  39% 42% 54% 
3 Cells+ 0.65M S-3 2% 0% - 
4 Cells+ 0.65M DMSO + 0.65M S-3 2% 0% - 
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Fig.5.6: Cell images after 1week cryopreservation using DMSO as well as 
trehalose dipivotate in protocols P-1& P-2 
 
 
 
Fig.5.7: Cell images after 1week cryopreservation using DMSO as well as 
trehalose dipivotate in protocols P-3& P-4 
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This chapter presented studies of the glass transition temperature, cell permeability and 
cryopreservation success of various trehalose derivatives. 
 
Of the four trehalose derivatives studied, only trehalose hexa acetate (S-5) showed no glass 
transition, while the other samples showed relatively high glass transitions compared to the 
most commonly used CPA-DMSO. 
 
Cell permeability studies showed that two of the compounds, S-3 and S-4, were cell permeable. 
In both cases the permeability was slower than for DMSO, with S-3 having a faster 
permeability than S-4. 
 
Initial cryopreservation trials were carried out with these two promising candidates. THP-1 
cells were cryopreserved using various concentrations and combinations of DMSO as well as 
the two compounds. Even though the cell viabilities using trehalose derivatives as CPAs were 
relatively low compared to those with DMSO as CPA, the viability was non-zero - ie, some 
cells survived.  
 
Trehalose dipivotate (S-3) showed the highest viability, so several cryopreservation protocols 
were trialed to see if viability might be improved. The results were disappointing, with all 
protocols worse than the standard one. 
 
These results have shown that trehalose derivatives are promising candidates for alternative 
CPAs and will be the steppingstone for further investigation of the cryoprotective nature of 
these and related compounds. Based on these results, future work will involve the development 
of further trehalose derivatives followed by physical testing and cryopreservation studies. 
 
In addition, cell membrane permeability to cryoprotectants and the optimum protocols for 
cryopreservation varies with cell type - for example, even though glycerol permeability is 
found to be low compared to that of other cryoprotectants such as DMSO, ethylene glycol and 
formamides17,18, many successful cryopreservation protocols still utilize glycerol. On the other 
hand, both methyl formamide and dimethyl formamide are reported as adequate alternative 
cryoprotectants for stallion sperm preservation yielding better survival than glycerol19-21. 
Similarly, DMSO is found to be a better cryoprotectant than glycerol and other cryoprotectants 
for some viruses22, methanotrophic bacteria23, yeasts24 etc. At the same time, DMSO has also 
been found to be toxic to some biological systems compared to other cryoprotectants25,26. Based 
on this variability, future studies will also include permeability and cryopreservation studies 
on other cell types to determine if these trehalose derivatives might be suitable as alternative 
CPAs for some cells. 
  
5.7 Conclusions and future work
48
 
  
1 Tarkowski, t. P. & Van den Ende, W. Cold tolerance triggered by soluble sugars: a 
multifaceted countermeasure. Frontiers in Plant Science 6, 203 (2015). 
2 Kent, B. et al. Direct comparison of disaccharide interaction with lipid membranes at 
reduced hydrations. Langmuir 31, 9134-9141, doi:10.1021/acs.langmuir.5b02127 
(2015). 
3 Lenné, T., Garvey, C. J., Koster, K. L. & Bryant, G. Effects of sugars on lipid bilayers 
during dehydration − SAXS/WAXS measurements and quantitative model. The 
Journal of Physical Chemistry B 113, 2486-2491, doi:10.1021/jp808670t (2009). 
4 Lenné, T., Bryant, G., Holcomb, R. & Koster, K. L. How much solute is needed to 
inhibit the fluid to gel membrane phase transition at low hydration? Biochimica et 
Biophysica Acta (BBA)-Biomembranes 1768, 1019-1022 (2007). 
5 Ross, M. F. et al. Accumulation of lipophilic dications by mitochondria and cells. 
Biochemical Journal 400, 199-208 (2006). 
6 Abazari, A. et al. Engineered trehalose permeable to mammalian cells. PloS One 10, 
e0130323, doi:10.1371/journal.pone.0130323 (2015). 
7 Murphy, M. P. & Smith, R. A. J. Targeting antioxidants to mitochondria by 
conjugation to lipophilic cations. Annual Review of Pharmacology and Toxicology 47, 
629-656, doi:10.1146/annurev.pharmtox.47.120505.105110 (2007). 
8 Kitamura, S. & Kuge, T. A differential scanning calorimetric study of the 
conformational transitions of schizophyllan in mixtures of water and 
dimethylsulfoxide. Biopolymers 28, 639-654, doi:10.1002/bip.360280208 (1989). 
9 Chiu, M. H. & Prenner, E. J. Differential scanning calorimetry: An invaluable tool for a 
detailed thermodynamic characterization of macromolecules and their interactions. 
Journal of Pharmacy and Bioallied Sciences 3, 39-59, doi:10.4103/0975-7406.76463 
(2011). 
10 Bonora, S., Markarian, S. A., Trinchero, A. & Grigorian, K. R. DSC study on the effect 
of dimethysulfoxide (DMSO) and diethylsulfoxide (DESO) on phospholipid liposomes. 
Thermochimica Acta 433, 19-26, doi:http://dx.doi.org/10.1016/j.tca.2005.02.011 
(2005). 
11 Wang, H.-Y., Lu, S.-S. & Lun, Z.-R. Glass transition behavior of the vitrification 
solutions containing propanediol, dimethyl sulfoxide and polyvinyl alcohol. 
Cryobiology 58, 115-117, doi:https://doi.org/10.1016/j.cryobiol.2008.10.131 (2009). 
12 Markarian, S. A., Bonora, S., Bagramyan, K. A. & Arakelyan, V. B. Glass-forming 
property of the system diethyl sulphoxide/water and its cryoprotective action on 
Escherichia coli survival. Cryobiology 49, 1-9, 
doi:http://dx.doi.org/10.1016/j.cryobiol.2004.04.001 (2004). 
13 Baudot, A. & Boutron, P. Glass-forming tendency and stability of aqueous solutions 
of diethylformamide and dimethylformamide. Cryobiology 37, 187-199, 
doi:http://dx.doi.org/10.1006/cryo.1998.2112 (1998). 
14 Baudot, A., Alger, L. & Boutron, P. Glass-forming tendency in the system water–
dimethyl sulfoxide. Cryobiology 40, 151-158 (2000). 
15 Ogawa, S., Takahashi, I., Koga, M., Asakura, K. & Osanai, S. Effect of freeze–thaw 
treatment on the precipitation of Octyl <i>β</i>-D-Galactoside hemihydrate crystal 
5.8 References
49
from the aqueous solution. Journal of Oleo Science 67, 627-637, 
doi:10.5650/jos.ess17232 (2018). 
16 Strober, W. Trypan blue exclusion test of cell viability. Current Protocols in 
Immunology 21, A. 3B. 1-A. 3B. 2 (1997). 
17 Meryman, H. Cryoprotective agents. Cryobiology 8, 173-183 (1971). 
18 Hubálek, Z. Protectants used in the cryopreservation of microorganisms. Cryobiology 
46, 205-229, doi:10.1016/s0011-2240(03)00046-4 (2003). 
19 Squires, E., Keith, S. & Graham, J. Evaluation of alternative cryoprotectants for 
preserving stallion spermatozoa. Theriogenology 62, 1056-1065 (2004). 
20 Alvarenga, M. A., Papa, F. O., Landim-Alvarenga, F. & Medeiros, A. Amides as 
cryoprotectants for freezing stallion semen: a review. Animal Reproduction Science 
89, 105-113 (2005). 
21 Medeiros, A., Gomes, G., Carmo, M., Papa, F. O. & Alvarenga, M. A. Cryopreservation 
of stallion sperm using different amides. Theriogenology, 273-276 (2002). 
22 Nagasaki, K. & Yamaguchi, M. Cryopreservation of a virus (HaV) infecting a harmful 
bloom causing microalga, Heterosigma akashiwo (Raphidophyceae). Fisheries Science 
65, 319-320 (1999). 
23 Green, P. & Woodford, S. Preservation studies on some obligately methanotrophic 
bacteria. Letters in Applied Microbiology 14, 158-162 (1992). 
24 Mikata, k. Preservation of years cultures by freezing at-80 C: I. Viability after 2 yeast 
storage and the effects of repeated thawing-freezing. IFO Res. Commun. 13, 59-68 
(1987). 
25 Nell, E. E. & Hardy Jr, P. H. The use of freeze-preserved treponemes in the 
Treponema pallidum immobilization test. Cryobiology 9, 404-410 (1972). 
26 Prentice, M. & Farrant, J. Survival of chlamydiae after cooling to-196 degrees C. 
Journal of Clinical Microbiology 6, 4-9 (1977). 
 
50
Chapter 6 
Measuring volume kinetics of human monocytes in response to 
cryoprotectants using microfluidic technologies  
 
This work has been peer reviewed and published as a research article in Applied Physics 
Letters. Citation of the publication is: 
 
Rekha Raju, Hannes Höhn, Christian Karnutsch, Khashayar Khoshmanesh, and Gary Bryant. 
"Measuring volume kinetics of human monocytes in response to cryoprotectants using 
microfluidic technologies." Applied Physics Letters 114, no. 22 (2019): 223702; 
https://doi.org/10.1063/1.5096199 
 
Author contributions: 
 
 
• I performed all cell permeability (volume kinetics) experiments, data analysis and 
interpretation, and wrote the initial draft of the manuscript. 
 
• I performed the design and fabrication of the microfluidic trapping structures in 
collaboration with Hannes Höhn under the guidance of Dr. Khashayar Khoshmanesh.  
 
• Prof. Gary Bryant advised on the data interpretation and contributed to the writing of 
the manuscript. 
 
• Dr. Khashayar Khoshmanesh and Prof. Christian Karnutsch contributed to the writing 
of the manuscript 
 
See Appendix II for the supplementary materials from this paper. 
 
 
 
Candidate’s Name:                      Ms. Rekha Raju Date 
11/11/2019 
 
 
Principal Supervisor’s Name:   Prof. Gary Bryant Date 
11/11/2019 
 
51
Appl. Phys. Lett. 114, 223702 (2019); https://doi.org/10.1063/1.5096199 114, 223702
© 2019 Author(s).
Measuring volume kinetics of human
monocytes in response to cryoprotectants
using microfluidic technologies
Cite as: Appl. Phys. Lett. 114, 223702 (2019); https://doi.org/10.1063/1.5096199
Submitted: 14 March 2019 . Accepted: 21 May 2019 . Published Online: 07 June 2019
Rekha Raju , Hannes Höhn, Christian Karnutsch, Khashayar Khoshmanesh , and Gary Bryant 
ARTICLES YOU MAY BE INTERESTED IN
Iontronic control of GaInAsP photonic crystal nanolaser
Applied Physics Letters 114, 221105 (2019); https://doi.org/10.1063/1.5098119
Measuring volume kinetics of humanmonocytes
in response to cryoprotectants using microfluidic
technologies
Cite as: Appl. Phys. Lett. 114, 223702 (2019); doi: 10.1063/1.5096199
Submitted: 14 March 2019 . Accepted: 21 May 2019 .
Published Online: 7 June 2019
Rekha Raju,1 Hannes H€ohn,2,3 Christian Karnutsch,2 Khashayar Khoshmanesh,3,a) and Gary Bryant1
AFFILIATIONS
1Centre for Molecular and Nanoscale Physics, School of Science, RMIT University, Melbourne, Victoria 3001, Australia
2Institute for Sensor- and Information Systems (ISIS), Research Group “Integrated Optofluidics and Nanophotonics (IONAS),”
University of Applied Sciences Karlsruhe, Karlsruhe 76133, Germany
3School of Engineering, RMIT University, Melbourne, Victoria 3001, Australia
a)Author to whom correspondence should be addressed: khashayar.khoshmanesh@rmit.edu.au
ABSTRACT
Cryopreservation is a common strategy for the preservation of biological cells and tissues. While conventional platforms such as cell culture
well plate systems enable measuring cell responses to various cryoprotectants, the drawbacks associated with capturing and imaging of cells
limit the utility of such systems. Microfluidic technologies facilitate the capturing, chemical stimulation, and imaging of cells using low
sample volumes. Here, we utilized microfluidic technologies for the hydrodynamic capturing of single human monocytes and studying the
cell volume kinetics in response to a cryoprotectant in real time. Our approach facilitates conducting multistep cellular assays, especially for
studying individual cell osmotic response and determining cell membrane permeability to cryoprotectants.
Published under license by AIP Publishing. https://doi.org/10.1063/1.5096199
Cryopreservation, the storage of samples in liquid nitrogen
(!196 "C), is generally used for preservation of cells and tissues.1–4
Cryopreservation protocols rely on the penetration of cryoprotective
agents (CPAs) to the cell to reduce the damage induced by the freezing
process. In this regard, studying the biophysical response of cells to
CPAs and especially the cell permeability is an important step in the
development of “cell specific” cryopreservation protocols.5
When cells are exposed to a hypertonic solution of permeable
solutes such as CPAs, the osmotic gradient across the cell membrane
leads to the efflux of water, resulting in the initial “shrinkage” of the
cells. The penetration of CPA into the cell reverses the osmotic gradi-
ent causing the influx of water, enabling the cell to “swell” back to
approximately its initial volume.6,7 Thus, the total cell response to
permeable CPAs can be described as a “shrink-swell behavior.”
Membrane permeability can be calculated from this volume response
using the Kedem-Katchalsky two-parameter transport equations.8–11
Several methods have been used to quantify the permeability of
cells based on their volume changes. These include the use of differen-
tial scanning calorimetry,12 electronic particle counters,13 stopped-
flow light scattering,14,15 and micropipette perfusion.16,17 However,
problems associated with the capture of cells, ambiguity of images,
exchange of solutions, and requirement of a large volume of cell
sample might limit the application of these methods.
Microfluidic technologies address these limitations, as they
enable the user to: (i) confine cells within a chamber/trap, preventing
imaging ambiguity due to overlapping of cells or their movement out
of the focus plane, (ii) monitor the changes of cellular conditions
following the perfusion of various isotonic and nonisotonic media, (iii)
analyze cell kinetics over extended periods without any dislodgement,
thus allowing for better image acquisition, and (iv) use low cell
numbers and reagent volumes.18–25 Due to these unique features,
microfluidic systems have been used for investigating cell membrane
transport properties such as permeability to water and CPAs.6,26–29
In the present study, we utilized microfluidic technology for
hydrodynamic capturing of single human monocytes (THP-1 cells)
and analyzing their volumetric response to CPAs in real-time.
We utilized cup-shaped21 and serpentine-shaped19 microfluidic
cell traps and compared their suitability for measuring the volumetric
response of THP-1 cells to CPAs. These microfluidic structures were
fabricated by direct laser writing using two-photon polymerization30
and replicated in poly-dimethylsiloxane (PDMS) using soft lithogra-
phy31 techniques. Direct laser writing facilitated the rapid prototyping
Appl. Phys. Lett. 114, 223702 (2019); doi: 10.1063/1.5096199 114, 223702-1
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of microfluidic structures with aspect ratios of # 9, which is rather
challenging using conventional lithography techniques.32 The fabrica-
tion involved design, preparation, laser writing, developing, replicat-
ing, and assembly, as described in supplementary material S1, and is
schematically shown in Fig. 1.
Figure 2 presents the experimental procedure, which can be
divided into five steps, including channel filling, cell loading, cell stabi-
lization, cell shrinking, and cell swelling, as described below.
Channel filling: This involved applying 70% ethanol solution for
degassing followed by applying phosphate buffered saline (PBS) and
RPMI1640 cell culture medium to fill the channel [Fig. 2(a)]. These solu-
tions were added into the inlet reservoir and withdrawn through the out-
let port using a syringe pump (PHD 2000 Infusion, Harvard Apparatus).
Cell loading: This involved applying an aliquot of cell suspension
(# 30–50ll, # 2.5 $ 105 cells/ml) to the channel to facilitate hydrody-
namic capturing of cells [Fig. 2(b)]. Further details on THP-1 cells can
be found in supplementary material S2.
Cell stabilization: This involved the withdrawal of RPMI1640 for
at least 30 s to enable cell equilibrium [Fig. 2(c)].
Cell shrinking: This involved applying a hypertonic solution of a
permeable CPA [dimethyl sulfoxide (DMSO)]. The higher extracellu-
lar osmolality of CPA led to the efflux of intracellular water, resulting
in the shrinkage of the cells [Fig. 2(d)].
FIG. 1. Fabrication process of the microfluidic traps combining direct laser writing
and soft lithography techniques.
FIG. 2. Studying the shrink-swell behavior of cells in response to permeable CPA
(DMSO) perfusion using a cup-shaped trap microfluidic device: (a) degassing and
channel filling, (b) cell loading, (c) cell stabilization, (d) cell shrinking following the
application of hypertonic DMSO, and (e) cell swelling due to the DMSO penetration
and subsequent water influx into the cell.
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Cell swelling: The constant water loss along with the constant
influx of CPA due to the concentration gradient across the cell mem-
brane reversed the osmotic gradient across the cell membrane just
after the cells experienced the maximum shrinkage. The reversed
osmotic gradient led to an influx of water into the cells, causing the
swelling of cells [Fig. 2(e)].
Figure 3 presents the cryoprotectant permeability measurement
of humanmonocyte cells using cup-shaped traps. This design incorpo-
rated an array of 17 independent traps [Fig. 3(a)]. Each trap had a
width of 25lm and a height of 35lm in order to capture and retain
individual THP-1 cells. Each trap consisted of four elements isolated
with a gap of 4lm to minimize the pressure drop and maximize the
chance of hydrodynamic trapping of cells. This gap was set to 4lm to
ensure that the cells would not squeeze through them and escape from
the traps.
This allowed us to capture single THP-1 cells and monitor their
dynamic volume changes in response to 10% (v/v) DMSO in real-time
[Fig. 3(b)], based on which we obtained the average volume kinetics of
multiple captured cells [Fig. 3(c)]. Numerical simulations revealed that
the concentration of CPA solution in the first few seconds of perfusion
and the hydrodynamic pressure are higher at the front side of the
trapped cells due to the direction of flow (supplementary material S3),
with both parameters affecting the osmotic gradient across the cell
membrane.
Images were captured using an inverted microscope (Olympus
IX71 inverted optical microscope) equipped with a CCD camera at a
resolution of 1024 $ 1024 and a CMOS sensor (Mikrotron MC1362).
For this camera (14lm/pixel on CCD, 10$ magnification, 1 $ 1 bin-
ning), the pixel size was obtained as image pixel size ¼ camera pixel
size $ binning/magnification ¼ 1.4lm, which was sufficient for mon-
itoring the THP-1 cells with a diameter range of 156 3lm (average
6 standard deviation). Images were processed using ImageJ (https://
imagej.nih.gov/ij/). Given the nonuniformity of the osmotic gradient
across the cell membrane, the area of trapped cells was measured using
the “freehand selections/measure” tabs of ImageJ, based on which the
equivalent radius and volume of the cells were calculated.
Our results indicated the instantaneous shrinkage of captured
cells due to water efflux in response to the osmotic gradient across the
cell membrane. The minimum cell volume was obtained as 73.3%
6 0.99% of the isotonic initial volume, which occurred at 236 1 s.
Next, the cells began to swell as DMSO diffused into the cells. During
this “swelling” phase, water also reenters the cells driven by the osmotic
pressure gradient generated by DMSO.
Figure 4 presents the results obtained by the serpentine-shaped
cell traps. Each trap had a width of 25lm and a height of 30lm with
a gap of 4lm at the downstream of each trap [Fig. 4(a)]. Similar
shrink-swell behavior was obtained [Fig. 4(b)]. The minimum cell
volume was obtained as 68.4%6 2.8% of the isotonic initial volume,
which occurred at 286 1s [Fig. 4(c)]. Compared to the cup-shaped
traps, the minimum cell volume increased by # 5% and delayed by
# 5 s. This is attributed to the localized deformation of the cells at their
backside facing the 4lm gap that significantly reduced the sphericity
FIG. 3. THP-1 cell volume kinetics using the cup-shaped cell trap in response to
hypertonic CPA solution 10% (v/v) DMSO in 0.9% PBS/NaCl: (a) cup-shaped cell
traps, (b) time-lapse images showing the volume changes of a representative THP-
1 cell, and (c) volume kinetics of four THP-1 cells captured with the average shown
as a black curve.
FIG. 4. THP-1 cell volume kinetics using the serpentine-shaped cell trap in
response to 10% (v/v) DMSO in 0.9% PBS/NaCl: (a) serpentine-shaped cell traps,
(b) time-lapse images showing the volume changes of a representative THP-1 cell,
and (c) volume kinetics of four THP-1 cells captured with the average shown as a
black curve.
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of the cell. Our experiments showed the superiority of cup-shaped
traps for (i) studying the shrink-swell behavior of cells due to a higher
number of captured cells per each channel (8cup vs 4serpentinne) and (ii)
maintaining the cell sphericity (0.913cup vs 0.822serpentinne) during the
cell shrinkage.
In summary, we investigated the volume kinetics (shrink-swell
behavior) of THP-1 cells in response to a CPA (DMSO) using micro-
fluidic technologies. Compared to existing technologies, our method
facilitated (i) rapid capturing of single cells without secondary mecha-
nisms such as surface functionalization, (ii) providing desired osmotic
gradients across the cell membrane by perfusing cryoprotective agents,
and (iii) real-time imaging of cells during the shrinkage and swelling
phases due to their stability. Future work includes developing micro-
fluidic systems with multiple trapping arrays to enable parallel study-
ing of cell volume kinetics to various CPAs and developing more
sophisticated microfluidic platforms capable of conducting multistep
cellular assays, paving the way for discovering CPAs.
See the supplementary material for S1: Fabrication details, S2:
Cell preparation process, and S3: Numerical simulations.
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Chapter 7 
General discussions, Conclusions and Future directions 
 
7.1 General discussions and conclusions 
The aim of this thesis was to examine the critical molecular properties that lead to good 
cryoprotective performance and use this knowledge to test novel non-toxic compounds which 
can be optimized to use as cryoprotectants. In order to achieve this aim, biophysical 
investigations of both traditional CPAs and novel potential candidate molecules were 
performed. This has been done by analyzing their cryobiologically important properties such 
as glass transition temperature, cell permeability and interaction with membrane lipids.  
The toxicity of currently employed CPAs imposes limitations on many biological and medical 
technologies. Two areas of critical medical importance are highlighted here as examples: 
• Stem cells which are pluripotent (i.e. can form stable cell culture lines which can 
differentiate) are difficult to cryopreserve1; such cells are vital for a wide range of stem 
cell therapies, and the ability to easily cryopreserve and culture these cell lines would be 
a major breakthrough in medical science. 
 
• Hepatocytes (liver cells) can be used as an alternative to liver transplants to treat liver 
disease or failure. Although they can be cryopreserved using DMSO, survival rates are 
low, making them impractical for transplants, and concerns have been raised about the 
DMSO toxicity2. Successful cryopreservation using less toxic CPAs would be of 
worldwide significance. 
To date the search for new CPAs has been reliant on educated guesswork and trial and error. 
This project, for the first time developed a systematic, quantitative understanding of the 
molecular properties vital to cryopreservation. This knowledge is essential to design new 
synthetic CPAs based on non-toxic carbohydrate derivatives. Focusing attention on 
carbohydrate derivatives will lead to promising new compounds which may be significantly 
less toxic than DMSO and glycerol. Tuning the molecular characteristics of these compounds, 
will help to systematically control their vitrification and cell permeation characteristics. 
Thus, the current study opens new avenues for the development of novel non-toxic 
carbohydrate-based CPAs vital to the field of cryopreservation. Interaction between the 
traditional penetrating CPAs and cell membrane lipids have been investigated using Langmuir 
monolayer technique. Carbohydrate derivatives (sugar surfactants) which have shown effective 
ice recrystallization inhibition (IRI) nature in the literature3-6 were selected for analysis as 
potential candidates with cryoprotective capability for achieving the goals of this research. 
Glass transition temperatures (Tg) of carbohydrate derivatives such as Octyl (thio) glycosides 
and trehalose derivatives were studied using Differential Scanning calorimetry (DSC). The 
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compounds which showed high Tg were used for further permeability studies. Cell 
permeability investigations were started with identifying the suitable cells. Literature review 
revealed that human monocyte leukemia (THP-1) cells are ideal for the purpose of this project.  
These cells are large (12-18µm) and spherical which are the two main criteria required for 
single cell permeability studies. Single cells were separated from cell solutions by traditional 
surface coating methods as well as by using microfluidic trapping technologies. The 
cryopreservation trials were conducted using standard cell lines (THP-1 cells) with standard 
freezing protocols, replacing the traditional CPA (eg. DMSO) with the promising candidate 
molecules.  
A chapter by chapter summary of the key results is presented below. 
Chapter 3 investigated the effects of four common cryoprotective agents (dimethyl sulfoxide, 
ethylene glycol, glycerol and dimethyl formamide) on phospholipid monolayers. Four different 
phospholipids (DOPC, DPPC, POPC & POPE) were studied to determine if the headgroup and 
level of chain saturation influence the interactions. DMSO showed interesting lipid specific 
effects – causing expansion of DPPC monolayers but compression for POPC monolayers, 
while having little effect for DOPC and POPE. These results demonstrate that the effects are 
subtle and conducting studies with a single model lipid is not sufficient to come to a complete 
understanding.  
For glycerol and EG, the results were largely consistent – each caused a small expansion of the 
monolayer at fixed pressure, regardless of lipid species, consistent with their ability to penetrate 
membranes. DMF showed the most interesting behavior. First, the presence of DMF caused a 
compression for all four lipid species – perhaps related to the small inherent surface activity of 
DMF, which reduced the surface tension by 5.6 mN.m-1 compared to pure water. This surface 
activity may also be responsible for the fact that DMF had the highest maximum insertion 
pressure (ie showed the strongest affinity to stay in the monolayer). DMF has been used as a 
cryoprotectant, but there have been very few studies of its lipid interactions and so more studies 
need to be done. 
The results highlight the need to study concentrations relevant to cryopreservation, as there is 
evidence of significant concentration dependence. Some of the conflicting results found in the 
literature appear to be due to concentration dependent differences. 
Finally, the insertion studies showed that the phospholipid species has a notable impact on the 
interactions with the CPAs. DPPC was the most difficult lipid to penetrate (as expected, as it 
is in the liquid condensed phase) while DOPC was the most facile. This study provided new 
insights into the interactions between lipids and traditional CPAs. 
Chapter 4 explored the cryobiologically important properties of eight n-octyl (thio)glycosides 
(1α, β – 4 α, β) to determine if they have cryobiological relevance. Of the compounds studied, 
n-octyl β-D-glucopyranoside 2β exhibited high sub-zero Tg values, both as a neat sample and 
as a 20 wt-% aqueous solution. Cell perfusion permeability assays exhibited favourable shrink–
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swell behaviour similar to DMSO. Promising cell permeability was observed for this 
compound, with low cytotoxicity provided the exposure time is kept within 160s, a reasonable 
time frame for exposure before cryopreservation. Glucoside 2β also displayed moderate IRI 
activity and therefore represents a promising compound for further biophysical and 
cryopreservation studies. 
Chapter 5 investigated the cryoprotective potential of four trehalose derivatives to assess their 
cryobiological promise. Three of the samples showed relatively high Tg between -100℃ and -
40℃, which were very high in comparison with the Tg of DMSO (~-130℃). Permeability trials 
on these molecules showed that S-2, trehalose-di acetate has no cell permeability, whereas both 
S-3 trehalose di pivotate and S-4 Trehalose tetra acetate have moderate permeability. The most 
promising candidate with high glass transition temperature and relatively good permeability 
was trehalose di pivotate (S-3), so this compound was further used for cryopreservation studies 
on THP-1 cells using various protocols. Unfortunately, the viability and the cell growth results 
were not promising compared to those of DMSO cryopreserved cells. Despite this, it is evident 
that this approach of making structural modification to naturally occurring cryoprotectants 
shows promise for the development of novel CPAs.  
Chapter 6 presented the design and implementation of new microfluidic cell trapping devices 
for studies of cryoprotectant permeability. Cup-shaped7 and serpentine-shaped8 microfluidic 
cell traps were fabricated by combining direct laser writing and soft lithography techniques 
and were tested by studying the volumetric response of THP-1 cells to DMSO. The 
experiments showed the superiority of cup-shaped traps for (i) studying the shrink-swell 
behavior of cells due to a higher number of captured cells per channel (8cup vs 4serpentinne) and 
(ii) maintaining cell sphericity (0.913cup vs 0.822serpentinne) during shrinkage. Using the two 
newly fabricated microfluidic devices, individual human monocyte cells could be successfully 
trapped, and their cell permeability was studied. The cells showed good shrink-swell behavior 
revealing the cryoprotectant permeability. Compared to existing technologies, the current 
method allowed: (i) rapid capture of single cells without surface functionalization; (ii) the rapid 
exchange of solvent to generate osmotic gradients across the cell membrane; and (iii) real-time 
imaging of cells during the shrinkage and swelling phases due to imaging stability provided by 
the traps. 
To the best of the author’s knowledge, this is the first time that the permeability of the human 
monocyte (THP-1) cells to DMSO has been measured using microfluidic technologies 
(Appendix III). Thus, this study also provided a platform to use this cell line as a tool for 
understanding the permeability of other potential cryoprotectants. 
The research presented here is significant as it is the first study to investigate two vital aspects 
of cryopreservation, namely cell permeability and vitrification, for new candidate CPAs. The 
study has shown the potential of new carbohydrate-based surfactants to be used as alternative 
CPAs with potential applications in biological science, medicine and food science. This thesis 
has resulted in two peer-reviewed journal articles, with a third currently undergoing peer-
review. The results of chapter 5 are currently being prepared for publication, and a literature 
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review based on chapter 1 will also be submitted for publication.  
7.2 Recommendations for the future work  
1. The Langmuir monolayer study highlighted the importance of different lipid species 
when measuring the interactions with potential CPAs. Thus, more studies are needed 
with membrane models other than the standard molecules (eg. DPPC), and with models 
which more closely mimic biological membranes. In particular, almost all previous 
studies have been conducted with zwitterionic (neutral) lipids. However, one might 
expect charged lipids (such as phosphatidylinositol) to play a significant role in 
interactions with polarizable molecules such as CPAs. Further studies of such systems 
are clearly needed. In addition to that, Langmuir monolayer studies of potential new 
CPAs will be an important part of understanding their interactions. Finally, this research 
highlighted the importance of concentration dependent effects - future studies should 
use concentrations relevant to cryopreservation. 
2. This work showed that modified carbohydrate-based surfactants such as octyl 
thioglycosides have the potential to be novel cryoprotective candidates, as they only 
showed toxicity on long-time contact with cells. Future research should include 
investigating the mechanisms of cellular uptake, as well as further biophysical and 
cryopreservation studies. 
3. This work has shown the potential of trehalose derivatives, which exhibit high glass 
transition temperatures, good cell permeability and relatively low toxicity. Cell viability 
after cryopreservation may be improved by further modifying the structure of these 
compounds, as well as optimisation of the cryopreservation protocols. Based on these, 
future work will involve the development of further trehalose derivatives followed by 
physical testing and cryopreservation studies. 
4. In addition, cell membrane permeability to cryoprotectants and the optimum protocols 
for cryopreservation varies with cell type - for example, even though glycerol 
permeability is found to be low compared to that of other cryoprotectants such as 
DMSO, ethylene glycol and formamides9,10, many successful cryopreservation 
protocols still utilize glycerol. On the other hand, both methyl formamide and dimethyl 
formamide are reported as adequate alternative cryoprotectants for stallion sperm 
preservation yielding better survival than glycerol11-13. Similarly, DMSO is found to be 
a better cryoprotectant than glycerol and other cryoprotectants for some viruses14, 
methanotrophic bacteria15, yeasts16 etc. At the same time, DMSO has also been found 
to be toxic to some biological systems compared to other cryoprotectants17,18. Based on 
this variability, future studies will also include permeability and cryopreservation 
studies on other cell types to determine if these trehalose derivatives might be suitable 
as alternative CPAs for some cells. 
5. Developing microfluidic systems with multiple trapping arrays will enable parallel 
study of cell volume kinetics to various CPAs. Therefore, future work will also include 
developing more sophisticated microfluidic platforms capable of conducting multistep 
cellular assays and thereby paving the way for discovering novel CPAs.  
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1.0 Materials and Methods 
General 
 
Analytical thin layer chromatography (TLC) was performed on commercially prepared silica 
plates (ChemSupply Silica Gel 60 0.20 mm F254). Flash column chromatography was 
performed using 230--400 mesh Kieselgel 60 silica eluting with distilled solvents as described. 
Solvents and reagents were purchased from Sigma-Aldrich and ChemSupply and used without 
further purification. Solvents for anhydrous reactions were distilled and dried accordingly. 1H 
NMR and 13C NMR spectra were recorded on a Bruker Ascend 500 NMR spectrometer at 
frequencies of 500 MHz and 125 MHz, respectively. Chemical shifts are reported as parts per 
million (ppm) downfield shift relative to the tetramethylsilane (TMS) internal standard (CDCl3 
only). The data are reported as chemical shift (δ), multiplicity, relative integral, coupling 
constant (J = Hz) and assignment where possible. IR spectra were recorded on a Perkin Elmer 
FT-IR (ATR) spectrometer. Optical rotation was measured on a Rudolph Research Analytical 
Autopol 1 automatic polarimeter (589 nm) using a 10 mL cell. ESI mass spectra were recorded 
on an Agilent 6120 single quadrupole mass spectrometer operating in positive mode unless 
otherwise stated.  
Differential scanning calorimetry 
 
DSC thermograms on warming were obtained with TA Instruments DSC 2920 Modulated 
differential scanning calorimeter using 5–10 mg of sample in hermetically sealed aluminum 
pans. Octyl (thio)glycosides were studied as neat samples and as 20% (w/v) aqueous solutions. 
For solutions, the samples were warmed from -120°C to 25°C at 5oC/min with one-minute 
equilibration times at the end points. Neat surfactants samples (5–10 mg) were hermetically 
sealed in aluminum sample pans and cycled between 25 oC and -160 oC at a rate of 10 oC/min, 
with one-minute equilibration times at the endpoints. For all samples, measurements were 
made on several (at least 2) successive runs to confirm the consistency in thermal behaviour.  
Tg values were interpreted as the extrapolated mid-point from the inflection of the curve.  
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Figure S1. DSC warming thermograms for compounds neat surfactants 1α, 3β, 4α, and 4β. 
Only the regions of interest are shown. Scans have been vertically offset for clarity. Possible 
glass transitions are indicated by bold arrowheads.  
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Figure S2. DSC cooling thermograms for soluble compounds (1β, 2α, 2β, and 3α), as 20% 
wt. aqueous solutions. Only the relevant temperature range is shown. The large endothermic 
peaks represent ice crystallisation.    
 
Cell permeability studies  
 
An aliquot of cell suspension (50--100 μL) was added to each well of a micro well plate. After 
the cells settled, the thioglycoside samples were added as small droplets slowly through the 
side walls of the wells avoiding any violent perturbation to the cell solution to ensure 
elimination of imaging ambiguities. Samples were prepared in RPMI1640 cell medium and 
used for cell perfusion with final concentrations 0.65M and 0.33M. For each sample and 
perfusion experiment, fresh cell suspensions were loaded to the micro wells from the incubator. 
The cell volume excursion history was recorded with live cell imaging using video microscopy. 
Video was recorded at 20 frames / second until osmotic equilibrium was obtained. All perfusion 
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images were captured for at least 5--10 minutes at room temperature (~22oC). An inverted 
microscope (Olympus IX71 inverted optical microscope) equipped with a CCD camera at 
1024×1024 resolution and a CMOS sensor (Mikrotron MC1362) was utilized for visualization. 
Automated time-lapse image acquisition was used for periods of up to 15 min under the control 
of StreamPix software (NorPix, Montreal) to capture the cell volume excursion history.  
The captured video was converted into image frames by exporting the full sequence at 1 
frame/sec. Cells were cropped from each frame of the image. Images were extracted and 
processed using ImageJ (https://imagej.nih.gov/ij/). Several images were analyzed at regular 
time intervals to understand the volume response (shrinking and swelling) of the cells. The 
areas of the selected cells were manually measured using oval/free hand selections. Radii and 
normalized volumes were calculated assuming the cells to be spheres. 
Ice recrystallization inhibition (IRI) analysis 
 
The ice recrystallization inhibition (IRI) activities of the thioglycosides were measured using 
the splat cooling assay.1 A 10 µL aliquot of the compound dissolved in phosphate-buffered 
saline (PBS) was dropped from a height of 2 metres onto a polished aluminium block cooled 
to approximately -80 °C using dry ice. The resulting circular ice wafer (approximately 1 cm in 
diameter and 20 µm thick) was transferred to a cryostage which was maintained at -6.4 °C 
using a programmable Peltier unit (S3 Series 800 temperature controller, Alpha Omega 
Instruments). The ice wafer was annealed for 30 minutes at -6.4 °C. Using a digital camera 
(Nikon CoolPix 5000) fitted to a microscope, images of the ice wafer were captured between 
crossed polarizing filters. A novel domain recognition software was then used to measure the 
cross-sectional areas of randomly-selected ice crystals in each of the three images analyzed per 
sample. The resulting mean grain size (MGS) of ice crystals was then calculated. IRI activities 
of the compounds are reported as percent mean grain size (% MGS) and compared to the % 
MGS of the positive control, PBS. The error bars in Figure 5 represent the percent standard 
error of the mean (% SEM). Testing for each compound was performed in triplicate. 
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Figure S3. IRI activities of thioglycosides 3α/β and 4α/β at their upper solubility limits in 
PBS. Inhibitory activity is depicted as percent mean grain size (% MGS) with error bars 
representing percent standard error of the mean (% SEM). 
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2.0 Synthesis  
 
Scheme S1. Synthesis of n-octyl (thio)glycosides 1–4.  
General method 1 -- synthesis of O-glycosides.2 
 
The synthesis was adapted from a procedure by Lindhorst and co-workers.2 To a stirred solution 
of the sugar pentaacetate (2.0 g, 5.1 mmol) in dry CH2Cl2 (10 mL) under N2 atmosphere was 
successively added 1-octanol (1.35 mL, 10.2 mmol, 2.1 equiv) and BF.Et2O (1.6 mL, 12.8 
mmol, 2.5 equiv) drop-wise. The solution was then stirred at room temperature for 4 h, at which 
time TLC analysis (1:1 ethyl acetate/petroleum spirit) indicated consumption of starting 
material and formation of product. The reaction was carefully neutralized by the drop-wise 
addition of saturated aqueous NaHCO3 solution (ca. 20 mL). CH2Cl2 (20 mL) was then added 
and the organic layer was separated and washed successively with saturated aqueous NaHCO3 
solution (2 x 20 mL) and brine (1 x 20 mL). The organic layer was dried with anhydrous 
Na2SO4, filtered, and evaporated. The residue was purified by flash silica chromatography (1:5 
v/v ethyl acetate-petroluem spirit) to give the optically pure α- and β-D-glycosides (1α/1β-
OAc and 2α/2β-OAc).  
General method 2 -- synthesis of S-glycosides.3 
 
The synthesis was adapted from a procedure by Wynberg and co-workers.3 To a stirred solution 
of the sugar pentaacetate (2.0 g, 5.1 mmol) in dry CHCl3 (10 mL) under N2 atmosphere was 
added 1-octanethiol (890 µL, 5.12 mmol, 1.0 equiv) followed by BF.Et2O (3.2 mL, 25.6 mmol, 
5.0 equiv) drop-wise. The deep red solution was then stirred at room temperature for 2 h, at 
which time TLC analysis (1:1 ethyl acetate/petroleum spirit) indicated consumption of starting 
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material and formation of product. The reaction was carefully neutralized by the drop-wise 
addition of saturated aqueous NaHCO3 solution (ca. 20 mL). CHCl3 (20 mL) was then added 
and the organic layer was separated and washed successively with saturated aqueous NaHCO3 
solution (2 x 20 mL) and brine (1 x 20 mL). The organic layer was dried with anhydrous 
Na2SO4, filtered, and evaporated. The residue was purified by flash silica chromatography 
(petroluem spirit / ethyl acetate, 4:1) to give the optically pure α- and β-D-thioglycosides 
(3α/3β-OAc and 4α/4β-OAc).  
General method 3 – deprotection of glycosides under Zemplén conditions.4  
 
Purified per-O-acetylated glycosides were deprotected using conditions adapted from Zemplén 
and Pascau.4 The per-O-acetylated glycoside was dissolved in anhydrous methanol and a 
freshly prepared solution of sodium methoxide (1 M in methanol) was added. The mixture was 
stirred until TLC indicated consumption of starting material and formation of a single product 
(ethyl acetate / methanol, 19:1). The mixture was neutralized by the addition of Amberlite 
IR120 (H+) resin, filtered, and evaporated to dryness to give pure n-octyl (thio)glycoside.  
 
n-Octyl (2,3,4,6-tetra-O-acetyl) α/β-D-galactopyranoside (1α-Ac  and 1β-Ac) 
 
 
 
 
Compounds 1α-Ac and 1β-Ac were synthesised according to general method 1. The anomeric 
mixture (2:3 α/β) was purified by flash chromatography as described to yield the pure α-
anomer (1α-Ac, 0.54 g, 1.17 mmol, 23%) and pure β-anomer (1β-Ac, 0.85 g, 1.83 mmol, 36%) 
as a colourless syrup.  
β-anomer (1β-Ac): Rf = 0.24 (petroleum ether/ethyl acetate, 4:1); [α]D20 = + 16.7 (c = 0.36, 
CHCl3); 1H NMR (500 MHz, CDCl3): δ = 5.38 (dd, 1H, J3,4 = 3.5 Hz , J4,5 = 1.0 Hz, H-4), 5.20 
(dd, 1H, J2,3 = 10.57, J1,2 = 8.08 Hz, H-2),  5.01 (dd, 1H, J2,3 = 10.5 Hz, J3,4 = 3.6 Hz, H-3), 4.45 
(d, 1H, J1,2 = 8.01 Hz, H-1), 4.18 (dd, 1H, J6a-6b = 11.25 Hz, J5-6a = 6.4 Hz, H-6a), 4.12 (dd, 1H, 
J6a-6b = 11.25 Hz, J5-6b = 7.05 Hz, H-6b), 3.91--3.86 (m, 2H, H-5, Gal-OCHH), 3.46 (dt, 1H, JCH-
CH = 9.60 Hz, JCH-CH2 = 6.61 Hz, Gal-OCHH), 2.14 (s, 3H, OAc CH3), 2.05 (s, 3H, OAc CH3), 
2.04 (s, 3H, OAc CH3),  1.98 (s, 3H, OAc CH3), 1.62--1.51 (m, 2H, Gal-OCH2-CH2), 1.32--1.23 
(m, 10H, 5 x CH2), 0.88 (t, 3H, J = 6.85 Hz, CH3) ppm; 13C NMR (125 MHz, CDCl3):  δ = 
O
OAcAcO
AcO
OAcO
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170.56, 170.45, 170.36, 169.51 (4 x COCH3), 101.48 (C-1), 71.11 (C-3), 70.68 (C-5), 70.44 
(Gal-OCH2), 69.07 (C-2), 67.21 (C-4), 61.42 (C-6), 31.92 (CH2), 29.53 (Gal-OCH2CH2),  29.40, 
29.37, 25.92, 22.77 (4 x CH2), 20.87, 20.81 (2), 20.73 (4 x COCH3), 14.21 (CH3) ppm. MS 
(ESI+): calcd. for C22H36O10 : m/z = 483.22 [M+Na]+; found: m/z = 483.2. 
α-anomer (1α-Ac): Rf = 0.31 (petroleum ether/ethyl acetate, 4:1); [α]D20 = +95.8 (c = 0.72, 
CHCl3); 1H NMR (500 MHz, CDCl3): δ = 5.46 (dd, 1H, J3,4 = 3.46 Hz, J4,5 = 1.32 Hz, H-4), 
5.37--5.34 (m, 1H, H-3), 5.12--5.09 (m, 2H, H-1, H-2), 4.24--4.21 (m, 1H, H-5), 4.13--4.06 (m, 
2H, H-6a, H-6b), 3.68 (dt, 1H, JCH-CH =  9.81 Hz, JCH-CH2 = 6.60 Hz, Gal-OCHH), 3.42 (dt, 1H, 
JCH-CH2 = 9.89 Hz,  JCH-CH2 = 6.61 Hz, Gal-OCHCH), 2.14 (s, 3H, OAc CH3), 2.07 (s, 3H, OAc 
CH3), 2.05 (s, 3H, OAc CH3), 1.99 (s, 3H, OAc CH3),  1.61--1.55 (m, 2H, Gal-OCH2CH2), 1.36--
1.26 (m, 10H, 5 x CH2), 0.89 (t, 3H, J = 6.94 Hz, CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 
170.33, 170.32, 170.20, 169.97 (4 x COCH3), 96.11 (C-1), 68.71 (Gal-OCH2), 68.33 (C-2), 
68.19 (C-4), 67.74 (C-3), 66.19 (C-5), 61.85 (C-6), 31.85 (CH2), 29.33 (Gal-OCH2CH2), 29.32, 
29.30, 26.11, 22.68 (4 x CH2),  20.79, 20.71 (2), 20.67 (4 x COCH3), 14.11 (CH3) ppm. MS 
(ESI+): calcd. for C22H36O10 : m/z = 483.22 [M+Na]+; found: m/z = 483.2. 
n-Octyl (2,3,4,6-tetra-O-acetyl) α/β-D-glucopyranoside (2α-Ac and 2β-Ac)  
 
O
OAc
AcO
AcO
OAcO
 
Compounds 2α-Ac and 2β-Ac were synthesised according to general method 1. The anomeric 
mixture (2:3 α/β) was purified by flash chromatography as described to yield the pure α-
anomer (2α-Ac, 0.61 g, 1.32 mmol, 26%) and pure β-anomer (2β-Ac, 0.90 g, 1.93 mmol, 38%) 
as a colourless syrup.  
β-anomer (2β-Ac): Rf = 0.22 (petroleum ether/ethyl acetate, 4:1); [α]D20 = +14.6 (c = 0.48, 
CHCl3); 1H NMR (500 MHz, CDCl3): δ = 5.20 (dd~t, 1H, J2,3 = J3,4 = 9.57 Hz, H-3), 5.09 (dd~t, 
1H, J3,4 = J4,5 = 9.61 Hz, H-4), 4.98 (dd, 1H, J2,3 = 9.62, J1,2 = 7.97, H-2), 4.49 (d, 1H, J1,2 = 7.99 
Hz, H-1), 4.26 (dd, 1H, J6a,6b = 12.23 Hz, J5,6a = 4.72 Hz, H-6a), 4.13 (dd, 1H, J6a,6b = 12.31 Hz,  
J5-6b = 2.45 Hz, H-6b), 3.87 (dt, 1H, JCH-CH = 9.70 Hz, JCH-CH2 = 6.33 Hz, Glc-OCHH), 3.69 (ddd, 
1H, J4,5 = 9.90 Hz, J5,6a = 4.73 Hz, J5,6b = 2.43 Hz, H-5), 3.47 (dt, 1H, JCH-CH = 9.57 Hz, JCH-CH2 = 
6.63 Hz, Glc-OCHH), 2.08 (s, 3H, OAc CH3), 2.04 (s, 3H, OAc, CH3), 2.03 (s, 3H, OAc CH3), 
2.01 (s, 3H, OAc CH3), 1.60--1.51 (m, 2H, Glc-OCH2-CH2), 1,34--1.23 (m, 10H, 5 x CH2), 0.88 
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(t, 3H, J = 6.81 Hz, CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 170.77, 170.39, 169.49, 169.35 
(4 x COCH3), 100.90 (C-1), 72.95 (C-3), 71.80 (C-5), 71.43 (C-2), 70.31 (Glc-OCH2), 68.56 
(C-4), 62.08 (C-6), 31.87 (CH2), 29.45 (Glc-OCH2CH2), 29.32 (2), 25.87, 22.71 (4 x CH2), 
20.81, 20.71, 20.70, 20.61 (4 x COCH3), 13.16 (CH3) ppm. MS (ESI+): calcd. for C22H36O10 : 
m/z = 483.22 [M+Na]+; found: m/z = 483.2. 
α-anomer (2α-Ac): Rf = 0.28 (petroleum ether/ethyl acetate, 4:1); [α]D20 = +91.0 (c = 0.56, 
CHCl3); 1H NMR (500 MHz, CDCl3): δ = 5.49 (dd~t, 1H, J2,3 = J3,4 = 9.80 Hz, H-3), 5.07--5.03 
(m, 2H, H-2, H-4), 4.85 (dd, 1H, J2,3 = 10.25 Hz, J1,2 = 3.81 Hz, H-2), 4.26 (dd, 1H, J6a,6b = 12.21 
Hz, J5-6a = 4.51 Hz, H-6a), 4.09 (dd, 1H, J6a,6b = 12.24 Hz, J5,6b = 2.41 Hz, H-6b), 4.02 (ddd, 1H, 
J4,5 = 10.25 Hz, J5,6a = 4.51 Hz, J5,6b =  2.41 Hz, H-5), 3.68 (dt, 1H, JCH,CH = 9.96 Hz, JCH,CH2 = 
6.58 Hz, Glc-OCHH), 3.42 (dt, 1H, JCH,CH = 9.82 Hz, JCH,CH2 = 6.58 Hz, Glc-OCHH), 2.09 (s, 3H, 
OAc CH3), 2.06 (s, 3H, OAc CH3), 2.03 (s, 3H, OAc CH3), 2.01 (s, 3H, OAc CH3), 1.62-1.55 
(m, 2H, Glc-OCH2CH2), 1.35-1.23 (m, 10H, 5 x CH2),  0.89 (t, 3H, J = 6.85 Hz, CH3) ppm; 13C 
NMR (125 MHz, CDCl3): δ = 170.76 (COCH3), 170.28 (COCH3), 170.25 (COCH3), 169.74 
(COCH3),  95.27 (C-1), 71.05 (C-2), 70.37 (C-3), 68.83 (Glc-OCH2), 68.74 (C-4), 67.22 (C-5), 
62.05 (C-6), 31.91 (CH2), 29.37 (Glc-OCH2CH2), 29.34 (2), 26.12, 22.74 (4 x CH2), 20.81 (2), 
20.76, 20.73 (4 x COCH3), 14.18 (CH3) ppm. MS (ESI+): calcd. for C22H36O10 : m/z = 483.22 
[M+Na]+; found: m/z = 483.2. 
n-Octyl (2,3,4,6-tetra-O-acetyl) α/β-D-thiogalactopyranoside (3α-Ac and 3β-Ac) 
 
 
 
 
Compounds 3α-Ac and 3β-Ac were synthesised according to general method 2. The anomeric 
mixture (~2:1 α/β) was purified by flash chromatography as described to yield the pure α-
anomer (3α-Ac, 1.31 g, 2.75 mmol, 54%) and pure β-anomer (3β-Ac, 0.78 g, 1.63 mmol, 32%) 
as a pale yellow syrup.  
β-anomer (3β-Ac): Rf = 0.30 (petroleum ether/ethyl acetate, 4:1); [α]D20 = -5.2 (c = 0.6, CHCl3); 
1H NMR (500 MHz, CDCl3): δ = 5.44 (dd, 1H, J3,4 = 3.44 Hz, J4,5 = 1.04 Hz, H-4), 5.23 (dd~t, 
1H, J2,3 = J1,2 = 9.95 Hz, H-2), 5.05 (dd, 1H, J2,3 = 9.95 Hz, J3,4 = 3.42 Hz, H-3), 4.84 (d, 1H, J1,2 
= 10.04 Hz, H-1), 4.17 (dd, 1H, J6a,6b = 11.28 Hz, J5,6a = 6.73 Hz, H-6a), 4.11 (dd, 1H, H6a,6b = 
O
OAcAcO
AcO
SAcO
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11.28 Hz, J5,6b = 6.73 Hz, H-6b), 3.95--3.91 (m, 1H, H-5), 2.75--2.63 (m, 2H, Gal-SCH2), 2.16 
(s, 3H, OAc CH3), 2.07 (s, 3H, OAc CH3), 2.05 (s, 3H, OAc CH3), 1.99 (s, 3H, OAc CH3), 1.66--
1.56 (m, 2H, Gal-SCH2CH2), 2.41--2.34 (m, 2H, CH2), 1.30--1.25 (m, 8H, 4 x CH2), 0.88 (t, 
1H, J = 7.02 Hz, CH3); 13C NMR (125 MHz, CDCl3): δ = 170.53, 170.38, 170.23, 169.71 (4 x 
COCH3), 84.40 (C-1), 74.53, 72.53, 67.45 (2), 61.59 (C-2, C-3, C-4, C-5, and C-6), 31.96, 
30.42, 29.85, 29.33, 29.29, 28.97, 22.89 (7 x CH2), 20.99, 20.85 (2) 20.77 (COCH3), 14.25 
(CH3) ppm.  MS (ESI+): calcd. for C22H36O9S : m/z = 499.2 [M+Na]+; found: m/z = 499.2 
α-anomer (3α-Ac): Rf = 0.37 (petroleum ether/ethyl acetate, 4:1); [α]D20 = +154.7 (c = 1.4, 
CHCl3); 1H NMR (500 MHz, CDCl3): δ = 5.72 (d, 1H, J1,2 = 5.18 Hz, H-1), 5.45 (dd, 1H, J3,4 = 
3.31 Hz, J4,5 = 1.15 Hz, H-4), 5.27 (dd, 1H, J2,3 = 11.01 Hz, J1,2 = 5.20 Hz, H-2), 5.22 (dd, 1H, 
J2,3 = 11.02 Hz, J3,4 = 3.27 Hz, H-3), 4.61--4.57 (m, 1H, H-5), 4.12 (dd, 1H, J6a,6b = 11.41 Hz, J5,6a 
= 6.15 Hz, H-6a), 4.09 (dd, 1H, J6a,6b = 11.41 Hz, J5,6b = 6.93 Hz, H-6b), 2.59--2.46 (m, 2H, Gal-
SCH2), 2.15 (s, 3H, OAc CH3), 2.08 (s, 3H, OAc CH3), 2.05 (s, 3H, OAc CH3), 1.99 (s, 3H, 
OAc CH3), 1.62--1.54 (m, 2H, CH2), 1.39--1.22 (m, 10H, 5 x CH2), 0.88 (t, J = 6.81 Hz, 3H, 
CH3) ppm; 13C NMR (125 MHz, CDCl3): δ = 170.29, 170.13 (2), 169.82 (4 x COCH3), 82.27 
(C-1), 68.31, 68.14, 68.11, 61.95, 66.58 (C-2, C-3, C-4, C-5, and C-6), 31.89, 29.95, 29.45, 
29.29, 29.21, 29.02, 22.75 (7 x CH2), 20.94, 20.79, 20.74 (2) (COCH3), 14.20 (CH3) ppm. MS 
(ESI+): calcd. for C22H36O9S : m/z = 499.2 [M+Na]+; found: m/z = 499.2 
n-Octyl (2,3,4,6-tetra-O-acetyl) α/β-D-thioglucopyranoside (4α-Ac and 4β-Ac) 
 
O
OAc
AcO
AcO
SAcO
 
Compounds 4α-Ac and 4β-Ac were synthesised according to general method 2. The anomeric 
mixture (~2:1 α/β) was purified by flash chromatography as described to yield the pure α-
anomer (4α-Ac, 1.24 g, 2.60 mmol, 51%) and pure β-anomer (4β-Ac, 0.85 g, 1.78 mmol, 35%) 
as a colourless syrup which slowly crystallized on standing in the refrigerator.  
β-anomer (4β-Ac): Rf = 0.27 (petroleum ether/ethyl acetate, 4:1); [α]D20 = -18.5 (c = 0.65, 
CHCl3); 1H NMR (500 MHz, CDCl3): δ 5.22 (dd~t, 1H, J2,3 = J3,4 = 9.36 Hz, H-3), 5.09 (dd~t, 
1H, J2,3 = J1,2 = 9.70 Hz, H-2),  5.03 (dd, 1H, J4,5 = 9.56 Hz, J3,4 = 9.42 Hz, H-4), 4.48 (d, 1H, J1,2 
= 10.05 Hz, H-1), 4.25 (dd, 1H, J6a,6b = 12.41 Hz, J5,6a = 4.92 Hz, H-6a), 4.14 (dd, 1H, J6a,6b = 
12.41 Hz, J5,6b = 2.42 Hz, H-6b), 3.71 (ddd, 1H, J4,5 = 9.62 Hz, J5,6a = 4.91 Hz, J5,6b = 2.44 Hz, 
12
 
 
H-5), 2.72--2.61 (m, 2H, Glc-SCH2), 2.08 (s, 3H, OAc, CH3), 2.06 (s, 3H, OAc, CH3), 2.03 (s, 
3H, OAc, CH3), 2.01 (s, 3H, OAc, CH3), 1.65--1.53 (m, 2H, Glc-SCH2-CH2), 1.40-1.22 (m, 
10H, 5 x CH2), 0.88 (t, 1H, J = 6.88 Hz, CH3); 13C NMR (125 MHz, CDCl3): 
δ 170.81, 170.37, 169.58, 169.55 (4 x COCH3), 83.79 (C-1), 76.01 (C-2), 74.08 (C-3), 70.05 
(C-4), 68.49 (C-5), 62.35 (C-6), 31.95, 30.17, 29.78, 29.33, 29.27, 28.95, 22.79 (7 x CH2), 
20.89 (2), 20.79, 20.76 (4 x COCH3), 14.25 (CH3) ppm. MS (ESI+): calcd. for C22H36O9S : m/z 
= 499.2 [M+Na]+; found: m/z = 499.2. 
α-anomer (4α-Ac): Rf = 0.37 (petroleum ether/ethyl acetate, 4:1); [α]D20 = +135.4 (c = 1.3, 
CHCl3); 1H NMR (500 MHz, CDCl3): δ 5.65 (d, 1H, J1,2 = 5.85 Hz, H-1), 5.37 (dd~t, 1H, J2,3 = 
J3,4 = 9.64 Hz, H-3), 5.04 (dd, 1H, J4,5 = 10.21 Hz, J3,4 = 9.50 Hz, H-4) 5.02 (dd, 1H, J2,3 = 10.23 
Hz, J1,2 = 5.85 Hz, H-2), 4.43 (ddd, 1H, J4,5 = 10.21 Hz, J5,6a = 4.71 Hz, J5-6b = 2.27 Hz, H-5), 
4.30 (dd, 1H, J6a,6b = 12.23 Hz, J5,6a = 4.69 Hz, H-6a), 4.07 (dd, 1H, J6a,6b = 12.31 Hz, J5,6b = 2.31 
Hz, H-6b), 2.58--2.46 (m, 2H, Gal-SCH2), 2.09 (s, 3H, OAc CH3), 2.06 (s, 3H, OAc CH3), 2.03 
(s, 3H, OAc CH3), 2.01 (s, 3H, OAc CH3), 1.39--1.21 (m, 10H, CH2), 0.88 (t, 3H, J = 6.93 Hz, 
CH3); 13C NMR (125 MHz, CDCl3): δ = 170.73, 170.08, 170.04, 169.78 (4 x COCH3), 82.13 
(C-1), 70.90 (C-2), 70.67 (C-3), 68.72 (C-4), 67.63 (C-5), 62.09 (C-6), 31.91, 30.29, 29.51, 
29.30, 29.22, 28.99, 22.76 (7 x CH2), 20.89, 20.86, 20.81, 20.76 (4 x COCH3), 14.22 (CH3) 
ppm. MS (ESI+): calcd. for C22H36O9S : m/z = 499.2 [M+Na]+; found: m/z = 499.2 
n-Octyl α-D-galactopyranoside (1α) 
 
 
 
 
Compound 1α were synthesised according to general method 3 and isolated as a waxy solid 
(352 mg, 1.12 mmol, 96%).  
1α: Rf = 0.44 (ethyl acetate/methanol, 6:1); [α]D20 = +95.3 (c = 0.53, CH3OH); 1H NMR (500 
MHz, CD3OD): δ 4.79 (d, 1H, J1,2 = 3.43 Hz, H-1), 3.89 (dd, 1H, J3,4 = 3.03 Hz, J4,5 = 1.13 Hz, 
H-4), 3.80 (td, J5,6 = 9.21 Hz, J3,4 = 1.13 Hz, H-5), 3.76 (dd, J2,3 = 10.10 Hz, J1,2 = 3.43 Hz, H-
2), 3.74--3.73 (m, 1H, H-3), 3.73--3.69 (3H, Gal-OCHH, H-6a, H-6b), 3.44 (dt, 1H, JCH,CH = 9.69 
Hz, JCH,CH2 = 6.57 Hz, Gal-OCHH), 1.70--1.57 (m, 2H, Gal-OCH2CH2), 1.42--1.27 (m, 10H, 5 x 
CH2), 0.90 (t, 3H, J = 7.12 Hz, CH3) ppm; 13C NMR (125 MHz, CD3OD): δ 13C NMR (125 
O
OHHO
HOO
HO
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MHz, CD3OD): δ 100.47 (C-1), 72.41 (C-5), 71.69 (C-3), 71.26 (C-4), 70.42 (C-2), 69.35 (Gal-
OCH2), 62,86 (C-6), 33.16 (Gal-OCH2CH2), 30.74 (2), 30.56, 27.49, 23.86 (4 x CH2), 14.58 
(CH3) ppm. MS (ESI+): calcd. for C14H28O6 : m/z = 315.2 [M+Na]+; found: m/z = 315.2. 
n-Octyl β-D-galactopyranoside (1β) 
 
O
OHHO
HO
OHO
 
Compound 1β were synthesised according to general method 3 and isolated as a waxy solid 
(554 mg, 1.76 mmol, 96%).  
1β: Rf = 0.36 (ethyl acetate/methanol, 6:1); [α]D20 =  -21.3 (c = 0.65, CH3OH); 1H NMR (500 
MHz, CD3OD): δ 4.20 (d, 1H, J1,2 = 7.48 Hz, H-1), 3.89 (dt, 1H, JCH,CH = 9.54 Hz, JCH,CH2 = 6.89 
Hz, Gal-OCHCH), 3.83 (dd, 1H, J3,4 = 3.32 Hz, J4,5 = 1.02 Hz, H-4),  3.75 (dd, 1H, J6a,6b = 11.30 
Hz, J5,6a = 6.63 Hz, H-6a), 3.72 (dd, 1H, J6a,6b = 11.30 Hz, J5,6b = 5.60 Hz, H-6b), 3.56--3.47 (m, 
3H, Gal-OCHH, H-2, H-5), 3.45 (dd, 1H, J2,3 = 9.68 Hz, J3,4 = 3.30 Hz, H-3), 1.68--1.59 (m, 2H, 
Gal-OCH2CH2), 1.41--1.27 (m, 10H, 5 x CH2), 0.90 (t, 3H, J = 7.19 Hz, CH3) ppm; 13C NMR 
(125 MHz, CD3OD): δ 105.12 (C-1), 76.67 (C-5), 75.19 (C-3), 72.73 (C-2), 70.99 (Gal-OCH2), 
70.49 (C-4), 62.57 (C-6), 33.15 (CH2), 30.98 (Gal-OCH2CH2), 30.73, 30.57, 27.27, 23.86 (4 x 
CH2), 14.58 (CH3) ppm. MS (ESI+): calcd. for C14H28O6 : m/z = 315.2 [M+Na]+; found: m/z = 
315.2. 
n-Octyl α-D-glucopyranoside (2α) 
 
O
OH
HO
HOO
HO
 
Compound 2α were synthesised according to general method 3 and isolated as a waxy solid 
(416 mg, 1.32 mmol, 100%).  
2α: Rf = 0.47 (ethyl acetate/methanol, 6:1); [α]D20 = +95.6 (c = 0.54, CH3OH); 1H NMR (500 
MHz, CD3OD): δ 4.78 (d, 1H, J1,2 = 3.78 Hz, H-1), 3.79 (dd, 1H, J6a,6b = 11.82 Hz, J5,6a = 2.40 
           
            
Hz, H-6a), 3.73 (dt, 1H, JCH,CH = 9.54 Hz, JCH,CH2 = 6.61 Hz, Glc-OCHCH), 3.67 (dd, 1H, J6a,6b = 
11.78 Hz, J5,6b = 5.46 Hz, H-6b), 3.63 (dd~t 1H, J2,3 = J3,4 = 9.22 Hz, H-3), 3.57 (ddd, 1H, J4,5 = 
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9.92 Hz, J5,6b = 5.52 Hz, J5,6a = 2.40 Hz, H-5), 3.44 (dt, 1H, JCH,CH = 9.65 Hz, JCH,CH2 = 6.38 Hz, 
Glc-OCHH), 3.38 (dd, J2,3 = 9.67 Hz, J1,2 = 3.73 Hz, 1H, H-2), 3.28 (dd, 1H, J4,5 = 9.91 Hz, J3,4 
= 8.97 Hz,  H-4), 1.70--1.57 (m, 2H, Glc-OCH2CH2), 1.43--1.26 (m, 10H, 5 x CH2), 0.90 (t, 3H, 
J = 7.10 Hz, CH3) ppm; 13C NMR (125 MHz, CD3OD): δ 100.22 (C-1), 75.28 (C-3), 73.77 (C-
5), 73.72 (C-2), 72.02 (C-4), 69.26 (Glc-OCH2), 62.80 (C-6), 33.16 (CH2), 30.78, 30.74, 30.57, 
27.28, 23.87 (5 x CH2), 14.59 (CH3) ppm. MS (ESI+): calcd. for C14H28O6 : m/z = 315.2 
[M+Na]+; found: m/z = 315.2. 
n-Octyl β-D-glucopyranoside (2β) 
 
O
OH
HO
HO
OHO
 
Compound 2β were synthesised according to general method 3 and isolated as a waxy solid 
(608 mg, 1.93 mmol, 100%). 
2β: Rf = 0.65 (ethyl acetate/methanol, 6:1); [α]D20 = -21.2 (c = 0.65, CH3OH); 1H NMR (500 
MHz, CD3OD): δ 4.24 (d, 1H, J1,2 = 7.82 Hz, H-1), 3.90 (dt, 1H, JCH,CH = 9.55 Hz, JCH,CH2 = 6.68 
Hz, Gal-OCHCH), 3.86 (dd, 1H, J6a,6b = 11.98 Hz, J5,6a = 2.01 Hz, H-6a), 3.66 (dd, 1H, J6a,6b = 
11.98 Hz, J5,6b = 5.41 Hz, H-6b), 3.53 (dt, JCH,CH = 9.33 Hz, JCH,CH2 = 6.79 Hz, Glc-OCHH), 3.34 
(dd~t, 1H, J2,3 = J3,4 = 9.10 Hz, H-3), 3.28 (dd~t, 1H, J2,3 = J3,4 = 9.10 Hz, H-4), 3.26--3.23 (m, 
1H, H-5), 3.16 (dd, 1H, J2,3 = Hz, J1,2 = Hz, H-2), 1.64--1.59 (m, 2H, Glc-OCH2CH2), 1.40--1.27 
(m, 10H, 5 x CH2), 0.90 (t, 3H, J = 7.12 Hz, CH3) ppm; 13C NMR (125 MHz, CD3OD): δ 104.43 
(C-1), 78.20 (C-3), 77.96 (C-5), 75.19 (C-2), 71.75 (C-4), 71.01 (Glc-OCH2), 62.86 (C-6), 
33.12 (CH2), 30.90 (Glc-OCH2CH2), 30.71, 30.53, 27.22, 23.83 (4 x CH2), 14.58 (CH3) ppm. 
MS (ESI+): calcd. for C14H28O6 : m/z = 315.2 [M+Na]+; found: m/z = 315.2. 
n-Octyl α-D-thiogalactopyranoside (3α) 
 
O
OHHO
HOS
HO
 
Compound 3α were synthesised according to general method 3 and isolated as a colourless 
gym (910 mg, 2.75 mmol, 100%).  
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3α: Rf = 0.53 (ethyl acetate/methanol, 6:1); [α]D20 = +200 (c = 0.8, CH3OH); 1H NMR (500 
MHz, CD3OD): δ 5.37 (d, 1H, J1,2 = 5.65 Hz, H-1), 4.21−4.18 (m, 1H, H-5), 4.07 (dd, 1H, J2,3 
= 10.16 Hz, J1,2 = 5.64 Hz, H-2), 3.90 (dd, 1H, J3,4 = 3.39 Hz, J4,5 = 1.22 Hz, H-4), 3.74−3.72 
(m, 2H, H-6a, H-6b), 3.62 (dd, 1H, J2,3 = 10.13 Hz, J3,4 = 3.36 Hz, H-3), 2.67−2.54 (m, 2H, Gal-
SCH2), 1.73−1.60 (m, 2H, Gal-SCH2-CH2), 1.46−1.29 (m, 10H, 5 x CH2), 0.92 (t, 3H, CH3) 
ppm; 13C NMR (125 MHz, CD3OD): δ 87.45 (C-1), 72.70 (C-5), 72.30 (C-3), 70.96 (C-4), 
69.86 (C-2), 62.66 (C-6), 33.12, 30.88 (2), 30.49, 30.46, 30.20, 23.83 (7 x CH2), 14.58 (CH3) 
ppm. MS (ESI+): calcd. for C14H28O6 : m/z = 315.2 [M+Na]+; found: m/z = 315.2. 
n-Octyl β-D-thiogalactopyranoside (3β) 
 
O
OHHO
HO
SHO
 
Compound 3β were synthesised according to general method 3 and isolated as an amorphous 
solid (538 mg, 1.63 mmol, 100%). 
3β: Rf = 0.56 (ethyl acetate/methanol, 6:1); [α]D20 = -19.2 (c = 0.8, CH3OH); 1H NMR (500 
MHz, CD3OD): δ 4.29 (d, 1H, J1,2 = 9.54 Hz, H-1), 3.88 (dd, 1H, J3,4 = 3.36 Hz, J4,5 = 0.95 Hz, 
H-4), 3.53 (dd~t, 1H, J1,2 = J2,3 = 9.48 Hz, H-2), 3.73 (dd, 1H, J6a,6b = 11.37 Hz, J5,6a = 6.81 Hz, 
H-6a), 3.68 (dd, 1H, J6a,6b = 11.37 Hz, J5,6b = 5.43 Hz, H-6b), 3.53--3.49 (m, 1H, H-5), 3.45 (dd, 
1H, J2,3 = 9.27 Hz, J3,4 = 3.35 Hz, H-3), 2.78--2.66 (m, 2H, Gal-SCH2), 1.71--1.59 (m, Gal-SCH2-
CH2), 1.44--1.26 (m, 10H, 5 x CH2), 0.90 (t, 3H, J = 6.92 Hz, CH3) ppm; 13C NMR (125 MHz, 
CD3OD): δ 87.82 (C-1), 80.65 (C-5), 76.36 (C-3), 71.56 (C-2), 70.56 (C-4), 62.66 (C-6), 33.12, 
31.21, 31.01, 30.48, 30.44, 30.13, 23.83 (7 x CH2), 14.58 (CH3) ppm. MS (ESI+): calcd. for 
C14H28O6S : m/z = 331.2 [M+Na]+; found: m/z = 331.2. 
n-Octyl α-D-thioglucopyranoside (4α) 
 
O
OH
HO
HOS
HO
 
Compound 4α were synthesised according to general method 3 and obtained as an amorphous 
solid (860 mg, 2.60 mmol, 100%).  
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4α: Rf = 0.56 (ethyl acetate/methanol, 6:1); [α]D20 = +218 (c = 0.38);  1H NMR (500 MHz, 
CD3OD): δ 5.30 (d, 1H, J1,2 = 5.51 Hz, H-1), 3.95 (ddd, 1H, J4,5 = 9.87 Hz, J5,6b = 7.73, Hz, J5,6a 
= 2.29 Hz, H-5), 3.79 (dd, 1H, J5,6a = 2.45 Hz, J6a,6b = 11.48 Hz, H-6a), 3.71 (dd, 1H, J6a,6b = 11.89 
Hz, J5,6b = 5.47 Hz, H-6b), 3.68 (dd, 1H, J2,3 = 9.72 Hz, J1,2 = 5.48 Hz, H-2), 3.52 (dd~t, J3,4 = J4,5 
= 9.21 Hz, 1H, H-4),  3.33--3.29 (m, 1H, H-3), 2.64--2.53 (m, 2H, GalS-OCH2), 1.68--1.59 (m, 
2H, GalSOCH2-CH2), 1.45--1.26 (m, 10H, 5 x CH2), 0.90 (t, 1H, J = 7.14 Hz, CH3) ppm; 13C 
NMR (125 MHz, CD3OD): δ 87.45 (C-1), 72.70 (C-5), 72.29 (C-2), 70.96 (C-3), 69.85 (C-4), 
62.66 (C-6), 33.12, 30.88 (2), 30.49, 30.46, 30.20, 23.83 (7 x CH2), 14.58 (CH3) ppm; 13C NMR 
(100 MHz, CD3OD): δ  87.30 (C-1), 73.30 (C-4), 74.04 (C-5), 75.80 (C-2), 71.85 (C-3), 62.66 
(C-6), 33.14, 31.19, 30.91, 30.51, 30.46, 30.17, 23.84 (7 x CH2), 14.58 (CH3) ppm. MS (ESI+): 
calcd. for C14H28O6S : m/z = 331.2 [M+Na]+; found: m/z = 331.2. 
n-Octyl β-D-thioglucopyranoside (4β) 
 
O
OH
HO
HO
SHO
 
Compound 4β were synthesised according to general method 3 and obtained as an amorphous 
solid (589 mg, 1.78 mmol, 100%). 
4β: Rf = 0.59 (ethyl acetate/methanol, 6:1); [α]D20 = -47.6 (c = 0.46, CH3OH); 1H NMR (500 
MHz, CD3OD): δ 4.35 (d, 1H, J1,2 = 9.73 Hz, H-1), 3.86 (dd, 1H, J6a,6b = 12.09 Hz, J6a,5 = 2.19 
Hz, H-6a), 3.66 (dd, 1H, J6a,6b = 12.04 Hz, J5,6b = 5.49 Hz, H-6b), 3.37-3.25 (m, 3H, H-3, H-4 
and H-5), 3.19 (dd, 1H, Hz, J1,2 = 9.78 Hz, J2,3 = 8.54 Hz, H-2),  2.79--2.67 (m, 2H, GlcS-OCH2), 
1.67-1.61 (m, 2H, GalS-OCH2-CH2), 1.45-1.28 (m, 10H, 5 x CH2), 0.91 (t, J = 6.94 Hz, CH3) 
ppm; 13C NMR (125 MHz, CD3OD): δ 87.23 (C-1), 82.07 (C-5), 79.70 (C-3 or C-4), 74.48 (C-
2), 71.57 (C-3 or C-4), 63.01 (C-6), 33.12, 31.16, 30.97, 30.48, 30.44, 30.14, 23.83 (7 x CH2), 
14.58 (CH3) ppm. MS (ESI+): calcd. for C14H28O6S : m/z = 331.2 [M+Na]+; found: m/z = 331.2. 
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NMR spectra (compounds 1β, 2α, 2β and 3α). 
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Supplementary Information S1: Fabrication process 
Microfluidic structures were fabricated by direct laser writing technique 1 using the 
Nanoscribe 3D printer (Nanoscribe GmbH, Germany) available at MicroNano Research 
Facility (MNRF), RMIT University, Melbourne. The fabrication involved design, 
preparation, laser writing, developing, replicating, and assembly, as briefly described here. 
Design: The microfluidic structures were designed in SolidWorks (Dassault Systèmes, 
France), and exported to DeScribe, which is the dedicated software of Nanoscribe 3D 
printer. The designs were based on the (i) Cup-shaped 2 and (ii) serpentine-shaped 3 arrays, 
both capable of hydrodynamic trapping and perfusion of single cells (Figure 1(a)).  
Preparation: The substrate (an indium tin oxide coated glass slide) was washed with acetone 
and isopropanol to remove all residuals, rinsed with distilled water and dried with nitrogen. 
The glass substrate was fixed to the holder of the Nanoscribe using glue. The photoresist 
was then poured on the substrate using a pipette. We used IP-S photoresist (Nanoscribe) due 
to its capability for the fast printing of smooth structures 4. The substrate was then checked 
visually to ensure no air bubbles were trapped in the photoresist.  
Laser writing: The system operated at a wavelength of 780 nm (near-infrared) in a 
femtosecond pulse mode at 100 fs and a repetition rate of about 80 MHz (Figure 1(b)). The 
system utilized an inverted microscope, Axio Observer (Carl Zeiss Micro Imaging GmbH, 
Germany), equipped with a 25× NA 0.8 objective. The microscope took advantage of an on-
board autofocus system to produce a focused laser beam at the substrate surface 4. The 
scanning speed and laser power were set to 10,000 µm/s and 0.5%, respectively.  
Developing: The substrate was inserted in a bath of SU-8 developer for 30 minutes, and then 
transferred into a bath of isopropanol for 2 minutes. These steps were required to remove the 
monomeric and other residual material.  
Replicating: The microfluidic traps were replicated using standard soft lithography 
processes 5-7. The silicon based PDMS elastomer base and curing agent were mixed at a 10:1 
weight ratio, stirred, degassed to remove any residual air bubbles, and poured onto the 3D 
printed structure to achieve a device thickness of 3-5 mm (Figure 1(c)). The PDMS 
structure was thermally cured at 70qC overnight.  
Assembling: The cured PDMS slab with embedded microfluidic structures was peeled off 
from the substrate and cut into a rectangular shape using a scalpel (Figure 1(d)). A 5 mm 
inlet reservoir and a 0.75 mm outlet port were punched to facilitate the interfacing of the 
microfluidic system with fluidic tubes. The PDMS slab was sealed onto a glass slide by 
plasma bonding (Harrick Plasma, Ithaca, NY) to avoid leakage. 
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Supplementary Information S2: Cell preparation 
Human monocytes (THP-1 cell lines) were purchased from ATCC (American Type Culture 
Collection, MANASSAS, VA). Cells were revived from liquid nitrogen and cultured 
according to ATCC standard protocol. Briefly, the cell culture consisted of RPMI1640 
medium (ATCC, 30-2001) supplemented with 10% FBS (Fetal Bovine Serum) (ATCC, 30-
2020) and 1% antibiotic (Penstrip). The cells were cultured in T25 flasks (Corning) inside an 
incubator at 37qC in a humidified atmosphere containing 5% CO2.  
The cells had a diameter ranging from 12 to 18 Pm. The viability of cells was measured using 
Trypan blue exclusion test 8 and found to be in the range of 96-98% before experiments. The 
cells were collected, centrifuged at 200 rcf for 5 min, and then re-suspended in 1× PBS 
(Phosphate Buffered Saline) (288 mosm/kg) at a cell density of 2.5×105 cells/ml, and used for 
experiments within 3 hours.  
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